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O Caderno 
 
Sou eu que vou seguir você 
Do primeiro rabisco 
Até o bê-a-bá 
Em todos os desenhos 
Coloridos vou estar 
A casa, a montanha 
Duas nuvens no céu 
E um sol a sorrir no papel 
 
Sou eu que vou ser seu colega 
Seus problemas ajudar a resolver 
Te acompanhar nas provas 
Bimestrais, você vai ver 
Serei, de você, confidente fiel 
Se seu pranto molhar meu papel 
 
Sou eu que vou ser seu amigo 
Vou lhe dar abrigo 
Se você quiser 
Quando surgirem 
Seus primeiros raios de mulher 
A vida se abrirá 
Num feroz carrossel 
E você vai rasgar meu papel 
 
O que está escrito em mim 
Comigo ficará guardado 
Se lhe dá prazer 
A vida segue sempre em frente 
O que se há de fazer 
 
Só peço, à você 
Um favor, se puder 
Não me esqueça 
Num canto qualquer 
Autor: Toquinho 
 
 
 
 
 
 
À minha filha Louiza Dal Lago Arend 
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Abstract  
Aging is associated with a decrease in cardiorespiratory and muscular fitness, 
flexibility, and also associated with the development of chronic diseases and low-
chronic adipose tissue inflammation. Regular physical activity, specifically aerobic 
and resistance exercises, has been advised in older persons for the prevention of 
chronic diseases and functional limitations. However, only a limited number of 
studies have evaluated the impact of concurrent combined training, namely in 
adipokine levels of older adults. The purpose of this thesis was to further explore the 
evidence of the benefit of 8-month combined aerobic (AT) and resistance exercise 
(RT) in body composition (BC), physical fitness (PF) and adipokine profile of older 
community adults. Furthermore, the secondary aim this study was to investigate the 
relationships of some adipokines with lipid profile markers and BC parameters in 
older untrained adults. To achieve these objectives, three studies were performed: 
The first was a cross-sectional study with 34 untrained older adults, in order to 
investigate the relationship of two adipokines (leptin and adiponectin) with lipid profile 
and BC parameters. The second study aimed to investigate the effects of 8-month 
combined AT and RT on BC and PF in the older adults. The third study aimed to 
investigate the effect of 8-month combined AT and RT on plasma levels of five 
adipokines: leptin, resistin, adiponectin, PAI-1 and TNF-α, as well as the lipid profile 
in older adults. 
Based on the analysis of the results of the different studies presented in this thesis, it 
was possible to conclude that, in older adults, leptin is a body and lean mass 
dependent variable, and adiponectin is a variable dependent on abdominal fat mass 
and HDL cholesterol. It was also possible to state that 8-month combined AT and RT 
improves knee flexor isokinetic strength, muscle endurance and lower limb flexibility, 
but not adipokine plasma levels, lipid profile and glucose plasma levels. 
This thesis further reinforce that concurrent training seems to be a good strategy to 
increase muscular strength, endurance, as well as flexibility, and consequently, to 
maintain functional capacity during aging. Further additional randomized studies with 
larger samples sizes are needed to evaluate the impact of the combined training in 
the adipokine profile of older subjects. 
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Resumo  
 
O envelhecimento está associado a uma diminuição da aptidão cardiorrespiratória e 
muscular, flexibilidade, e também ao desenvolvimento de doenças crônicas e 
inflamação crônica do tecido adiposo. A atividade física regular, especificamente 
com exercícios aeróbios e de resistência, tem sido descrita como um agente 
promotor da saúde e de prevenção de doenças crónicas e de limitações funcionais 
nos idosos. No entanto, apenas um número limitado de estudos avaliou o impacto 
do treino concorrente combinado, em particular nos níveis de adipocinas em idosos. 
Assim, o objetivo desta tese, foi de  explorar o potencial benefício do treinamento 
combinado de 8 meses com exercício aeróbio (TA) e de resistência (TR) na 
composição corporal (CC), aptidão física (ApF) e perfil plasmático de adipocinas, 
além de investigar as associações de algumas adipocinas com marcadores do perfil 
lipídico e da CC em idosos. Para alcançar esses objetivos, foram realizados 3 
estudos: o primeiro foi um estudo transversal com 34 idosos destreinados, cujo 
objetivo foi investigar as associações de duas adipocinas (leptina e adiponectina) 
com marcadores do perfil lipídico e com a CC. O segundo estudo teve como objetivo 
investigar os efeitos de um treinamento combinado, de 8 meses, TA e de TR, na CC 
e ApF em idosos. O terceiro estudo investigou os efeitos de um treinamento aeróbio 
e de resistência combinados por 8 meses nos níveis plasmáticos de 5 adipocinas: 
leptina, resistina, adiponectina, PAI-1 e TNF- alfa, bem como no perfil lipidico dos 
idosos. 
Os resultados dos diferentes estudos mostraram que nos idosos estudados, a 
leptina foi uma variável dependente da massa corporal e da massa magra, e a 
adiponectina foi uma variável dependente da massa gorda abdominal e dos níveis 
de lipoproteínas de alta densidade (HDL). Também foi possível afirmar que o 
treinamento combinado melhorou a força isocinética dos flexores do joelho, a 
resistência muscular e a flexibilidade dos membros inferiores dos idosos estudados, 
sem interferir, no entanto, nos níveis plasmáticos das adipocinas, no perfil lipídico e 
na glicemia. 
Podemos concluir que o treinamento concorrente parece ser uma boa estratégia 
para aumentar a força e a resistência muscular,  a flexibilidade e, 
consequentemente, manter a capacidade funcional durante o envelhecimento. Por 
fim, salientamos que outros estudos randomizados com amostras maiores são 
necessários, a fim de avaliar o impacto do treinamento combinado no perfil 
plasmático de diversas adipocinas. 
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The dramatic increase in average life expectancy ranks as one of society’s 
greatest achievements (Explained, 2017a). The European population is 
growing older, a phenomenon extensively eminent and described, with 
significant implications for the nation's health, social, and economic 
institutions (Explained, 2017b).  
Although aging is a multifactorial process that results from the interaction of 
the primary aging process with the effects of life style, genetics and chronic 
diseases, age-related functional and structural decline occurs in most 
physiological systems (Fried et al., 2004).  This process is associated with a 
decreased cardiorespiratory and muscular fitness, and flexibility (Milanovic et 
al., 2013), and is also associated with the development of chronic diseases, 
such as hypertension, dyslipidemia, diabetes, and obesity (Kennedy et al., 
2014). In this context, functionality and several chronic diseases can have a 
profound impact on the health and quality of life of older persons (Carvalho, 
2004; Holland GJ, 2002). 
Disability and death associated with chronic diseases and decline in functional 
capacity might be prevented by regular physical activity. It has been 
demonstrated that aerobic and resistance training can increase average life 
expectancy through its influence on chronic diseases development, through 
the mitigation of age-related biological changes and their associated effects 
on health and well-being, and through the preservation of functional capacity 
(American College of Sports et al., 2009). 
Current evidence point that aerobic training  (AT) mainly improves aerobic 
capacity and reduces body fat, while resistance training (RT) primarily results 
in increases in muscle strength and mass (Willis et al., 2012). Furthermore, 
combined aerobic and RT may lead to gains in muscular strength (Izquierdo 
et al., 2004; Wood et al., 2001) and cardiovascular fitness (Gudlaugsson et 
al., 2012), as well as improved load-carrying walk performance (Izquierdo et 
al., 2005), when compared with either modality alone in older adults. 
However, most studies have been performed with combined AT and RT 
alternating schedules, and the effects of exercise programs that combine both 
dimensions in single sessions, known as concurrent training (Lee et al., 
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2015), are still doubting. Thus, this thesis proposes to further explore the body 
of evidence of the potential benefit of combined AT and RT in body 
composition and physical performance in older adults. 
Furthermore, aging is also associated with a decline in tissue function and an 
increase in disease burden, and adipose tissue is no exception. With aging, 
adipose tissue undergoes significant changes in abundance, distribution, 
cellular composition, and endocrine signalling, and plays a central role in the 
development of insulin resistance, metabolic dysfunction, inflammation, and 
impaired regenerative capacity with age (Tchkonia et al., 2010). The age-
related increased fat mass, especially in the visceral depot, is responsible of 
worsening insulin resistance and glucose tolerance, dyslipidemia, 
hypertension and obesity (Kuk et al., 2009).  
Adipose tissue is now known to express and secrete a variety of bioactive 
peptides, known as adipokines, which act at both the local 
(autocrine/paracrine) and systemic (endocrine) level. The dysregulation of 
these adipose-tissue derived bioactive molecules is recognized as common 
ground for insulin resistance, metabolic syndrome, atherosclerosis, obesity, 
and aging (Arai et al., 2011; Wang & Nakayama, 2010). Increasingly, chronic 
inflammation is being linked to aging and chronic disease.  
Moreover, currently there are limited numbers of studies that have evaluated 
the impact of combined training in adipokine levels of older adults (Beavers, 
Brinkley, et al., 2010; Brooks et al., 2007; Gondim et al., 2015; Jorge et al., 
2011; Ligibel et al., 2009; Markofski et al., 2014). Generally, the scarce 
previous studies demonstrated no benefit of the combined exercise in 
adipokine profile, but they are heterogenous in the length of training time, 
supervision and had used different methodologies in the training protocol, 
using, most of them, alternate work week schedules of AT and RT, and not 
combining both dimensions in single sessions. So, the second part of this 
thesis further explores the potential benefit of the concurrent aerobic and 
resistance training on the plasma adipokine levels of older adults.  
In order to achieve these objectives, this thesis was organized into six 
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chapters. The first, second, and third chapters contains, respectively, a brief 
introduction, background of the theme and the main objectives of the study. 
The following chapter was devoted to the experimental work, which includes 
three original studies, submitted to peer-reviewed scientific journals. The final 
two topics (chapter 5 and 6) report the final remarks and the main conclusions 
of the thesis.   
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Chapter 2 -Theoretical Background   
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Age-Related Changes and Chronic diseases in older person  
In 2015, the population of the European Union was estimated to be 508.5 
million. Young people (0 to 14 years old) were 15.6 % of the population, while 
persons considered being of working age (15 to 64 years old) accounted for 
65.6 % of the population and older persons (aged 65 or over) represented 
18.9 %  (an increase of 0.4 % compared with the previous year and an 
increase of 2.3 % compared with the previous 10 years) (Explained, 
2017a).The median age of the EU-28’s population was 42.4 years on 1 
January 2015. Between 2005 and 2015 the median age increased in all of the 
EU Member States, rising by more than 4.0 years in Lithuania, Portugal, 
Greece and Germany (Explained, 2017c).  
Population ageing is a long-term trend already started several decades ago in 
Europe. This trend is visible in the transformations of the age population 
pyramid that reflects an increasing proportion of older persons coupled with a 
declining proportion of working-age persons in the total population (Explained, 
2017c). Within the last decade (2005–15), there was an increase of 2.3% of 
the population aged 65 years or older. The number people ≥ aged 65 years 
worldwide is expected to nearly triple by 2050, with the ‘‘oldest old’’ group (≥ 
85 years) being the most rapidly expanding segment. In Europe, the median 
life expectancy increased 3.8 years for women and 2.7 years for men 
between 2002 and 2014 (Explained, 2017c).  
Aging is a complex process involving many factors that interact with one 
another, including “primary aging” process, ‘‘secondary aging’’ effects 
(resulting from chronic disease and lifestyle behaviors), and genetic factors 
(Weinert & Timiras, 2003). This is an involuntary and inevitable process that 
causes progressive structural and functional loss in the body, such as 
deterioration of functional capacity, muscle mass and strength loss (mainly 
due to sarcopenia), loss of bone mass and of hormone production, and delays 
in reaction time, which are risk factors that lead to a loss of autonomy and 
increased risk of falling (Cederholm et al., 2013; Sherrington et al., 2008). 
A growing challenge is to maintain elderly people independently until end of 
life. The functional independence is directly in need of physical fitness, i.e. 
‘‘the ability to carry out daily tasks with vigor and alertness, without undue 
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fatigue and with ample energy to enjoy [leisure] and to meet unforeseen 
emergencies”. The physical fitness is determined by several measurable 
health-related phenotypes, including, among others, cardiorespiratory fitness 
and muscle function. Among the physiological changes associated with aging, 
those affecting the cardiorespiratory and vascular system and skeletal 
muscles are the ones that most affect physical fitness (Garber et al., 2011). 
With advancing age, structural and functional deterioration occurs in most 
physiological systems, even in the absence of discernable disease (Masoro, 
1995). These age-related physiological changes affect a broad range of 
tissues, organ systems, and functions, which, cumulatively, can impact on 
activities of daily living (ADL) and therefore in the preservation of physical 
independence in older adults. Besides the decline in maximal aerobic capacity 
(VO2max) and skeletal muscle performance (Holloszy, 1995), changing in 
body composition is another hallmark, which has profound effects on health 
and physical function among older adults. Specific examples include the 
gradual accumulation of body fat and its redistribution to central and visceral 
depots during middle age and the loss of muscle during middle and old age, 
with increased risk of metabolic and cardiovascular diseases (Janssen & 
Ross, 2005; Racette et al., 2006). 
As population continues to grow and get older, the prevalence of chronic 
illness is likely to increase. Metabolic and cardiovascular diseases are one of 
the most critical global health threat as they are associated with increased 
mortality and contribute to more than one-third of the global morbidity (Strait & 
Lakatta, 2012). For older adults, chronic disease is often linked to a higher 
rate of injuries, functional limitations, and cognitive impairments (Fisher & 
McCabe, 2005). Consequently, the increase in chronic disease rates has 
created an enormous social, emotional, and economic burden that prevails 
throughout the world (Yach et al., 2004). 
Cardiovascular diseases (CVD) are common in the general population, 
affecting the majority of adults aged 60 years or older. In 2012 and 2013, CVD 
were estimated to result in 17.3 million deaths worldwide on an annual basis 
(Laslett et al., 2012). Despite increases in longevity and decreases in age-
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specific death rates from CVD, CVD and its related complications remain 
highly prevalent (George et al., 2015). It’s estimated that a great number of 
the aged subjects will have morbidity and mortality related to cardiovascular 
disease, with up to 85% of cardiovascular disease patients over 65 years 
(Pohlel et al., 2006).  
Dyslipidemia is a modifiable risk factor for CVD. Aging is associated with 
multiple, systemic dysfunctions of the body and accompanied by lipid 
metabolism disorder and chronic inflammatory state, which contribute to 
atherosclerotic cardiovascular disease (Perdomo & Henry Dong, 2009).  
Dyslipidemia is characterized by increased triglyceride and/or low-density 
lipoprotein (LDL) levels, and also declined high-density lipoprotein (HDL) 
levels. Such an atherogenic lipid profile often predisposes individuals at risk to 
coronary artery disease with incompletely understood mechanisms (Perdomo 
& Henry Dong, 2009). Of particular interest is the fact that plasma levels of 
total cholesterol and LDL cholesterol (LDL-C) are well known to increase with 
normal aging, while HDL cholesterol (HDL-C) is declining with age (Ericsson 
et al., 1997; Ericsson et al., 1991). Elevated plasma LDL-C levels represent 
one of the most important risk factors for the development of atherosclerosis 
and subsequent CVD and are in fact a prerequisite for other risk factors such 
as smoking, inflammation, diabetes and hypertension. The clustering of above 
factors has been demonstrated to steadily increase the incidence of 
cardiovascular diseases (Ye et al., 2005). The Heart Protection Study (HPS) 
(2002) and the Cholesterol Treatment Trialists meta-analysis demonstrated 
that a reduction in LDL-C of 1 mmol/L was associated with a 20% reduction in 
clinical cardiovascular events (Cholesterol Treatment Trialists et al., 2010). 
The gender differences in lipid and lipoprotein levels are further affected by 
age. In human observations, the Framingham Study has demonstrated that 
aging is associated with a gradual increase in plasma LDL-C levels in men 
and women between 20 and 60 years (Abbott et al., 1983). After the age of 20 
years, the plasma LDL-C concentrations increase progressively in men and 
women, but more rapidly in men, accounting for most of the overall gender 
differences in cholesterol levels. (Ericsson et al., 1991; Ferrara et al., 1997). 
However, menopause in women often causes an increase in their plasma 
 25 
LDL-C, and after the age of 50, women often have higher total cholesterol 
levels than men of the same age (Kreisberg & Kasim, 1987). Interestingly, the 
LDL-C levels have a plateau in men between the age of 50 and 60 years, and 
in women between the age of 60 and 70 years (Gobal & Mehta, 2010).  
It has been well documented that obesity is associated with increased risk for 
many chronic conditions including coronary heart disease (Tanne et al., 
2005), stroke (Winter et al., 2008) and diabetes mellitus (Narayan et al., 
2007), as well as disease risk factors such as hypertension (Sardinha et al., 
2000) and dyslipidemia (Williams et al., 1997). Indeed, the evidence suggests 
that a central distribution of body fat (subcutaneous or visceral) is much more 
closely related with an atherogenic metabolic profile than total body fat 
(Sardinha et al., 2000). Abdominal obesity, the fat around the waist and within 
the abdominal cavity, may be a critical risk factor for developing these 
metabolic and cardiovascular diseases. Reduced abdominal fat is an 
important feature of the exercise training response and may help to improve 
cardiovascular health, particularly in reducing the risk of type 2 diabetes and 
hypertension (Stewart, 2005).  
Abundant evidence shows that diabetes is an independent and high risk factor 
for (Grundy et al., 1999). Type 2 diabetes mellitus (DM) is a growing problem 
worldwide, because of long life expectancy and life style modifications. In old 
age (≥60 years old), DM is becoming an alarming public health problem in 
developed and even in developing countries as for some authors one from 
two old persons are diabetic or pre-diabetic and for others 8 from 10 old 
persons have some dysglycemia (Lozano et al., 2012). The prevalence of 
type 2 diabetes continues to increase steadily as more people live longer and 
grow heavier. Older adults with diabetes are at risk of developing a similar 
spectrum of macrovascular and microvascular complications as their younger 
counterparts with diabetes. In addition, they are at high risk for functional 
disabilities (Kirkman et al., 2012). 
Giving the positive effects of exercise on physical function and CVD and 
metabolic diseases, healthy aging might require an intervention that involves 
regular exercise (Evans, 2002). 
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Aging, Physical Fitness and Body Composition 
Components of Physical Fitness   
Aerobic Endurance  
Aerobic endurance means the ability of the cardiopulmonary system to carry 
blood and oxygen to the active muscles and those using oxygen and energy 
substrates for a maximum effort (Hawkins & Wiswell, 2003).It has been 
described that with increasing age this ability is decreased by a reduction in 
the maximum cardiac output and in the capillarization of the skeletal muscle 
mass (Hollmann et al., 2007). There are also associated peripheral changes, 
such as increased vascular resistance with consequent increase in arterial 
blood pressure and inability to drive blood to the active muscles (Hollmann et 
al., 2007). Further, there are modifications in body composition (decrease in 
lean body mass and increasing fat mass), which can reflect a decrease of 
oxygen utilization by skeletal muscle (Fletcher et al., 2001). These 
morphological, physiological and functional changes in the cardiovascular and 
muscular system drastically limit the cardiovascular capacity contributing to 
the prevalence of functional limitations, disturbing the ability to perform basic 
life activities (Hurley & Roth, 2000; Toraman et al., 2004).  
The boundary of the body capacity to take and distribute the oxygen (O2) and 
exceed the metabolic requirements of prolonged vigorous exercise is 
represented by VO2max, defined as the maximum amount of work that can be 
carried by the body using the oxidative metabolism (Hawkins & Wiswell, 2003; 
Spirduso, 2005). This parameter is considered the reference standard for 
aerobic capacity and decreases about 5 to 15% per decade after 25 years in 
sedentary individuals and about 5% in active individuals are observed 
(American College of Sports, 1998). The VO2max declines in both sexes in a 
similar proportion and at around 75 years of age most seniors shows VO2max 
values below the values required for the realization of many of the basic life 
activities (Hawkins & Wiswell, 2003). There is a close relationship between 
downsizing VO2max and respiratory and/or cardiovascular disease (Spirduso, 
2005). The age decline in VO2max is accentuated in the presence of chronic 
diseases (Fleg et al., 2005; Paterson et al., 2007), with significant implications 
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in functional independence and quality of life (QoL) of older persons (Fleg et 
al., 2005). 
In this sense, it is important to maintain or improve aerobic capacity in the 
elderly, as this ability has direct implications for their mobility, facilitating their 
participation in more activities, social contacts, and health (Fleg et al., 2005). 
Several studies suggest that the decline in physical performance associated 
with age can be minimized by regular aerobic endurance training. For 
example, one study (Evans, 1999)  conducted with a 10 to 12 month training 
program for elderly with various forms of aerobic activity, and progressive 
VO2max intensity between 60% -75% demonstrated gains of about 15% 
VO2max. Also cross-sectional studies with elderly indicate that more active 
individuals tend to show higher levels of cardiorespiratory fitness when 
compared to sedentary individuals (Oja, 2001). According to some authors 
(Hawkins & Wiswell, 2003; Malbut et al., 2002; Westerterp & Meijer, 2001), 
the response of the cardiovascular system to training stimulus remains 
adapted in different age groups, with observed relative increases in VO2max 
in adults of any age, that are equivalent to those observed in young 
individuals. 
 
Muscular Strength   
Muscle strength is considered a critical component of physical fitness to 
maintain an optimal driving function and hence a good QoL (Rikli&Jones, 
2001). With aging, there is a reduction in the mass, strength and power of the 
skeletal muscles, resulting in the designated sarcopenia, which translates to a 
loss of muscle quantity and quality (Baker, 2006). This mainly occurs from the 
5th decade, becoming more pronounced after the seventh decade (Rogers & 
Evans, 1993), and is mainly due to the decrease in the number and size of 
muscle fibers, with resulted decreased  muscle mass assigned to disuse 
(Pedersen & Saltin, 2006). 
In addition to the atrophy and hypoplasia with advancing age, several studies 
have suggested that reductions in neural recruitment capacity mechanism 
could also contribute significantly to the functional changes observed in the 
elderly (Hoffman & Morcom, 2018). 
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The decrease in strength is not proportional in all types of muscle groups and 
muscle contraction (Behm et al., 2002; Spirduso, 2005; Vandervoort, 2002). 
Different studies in older subjects show that the decrease in strength is more 
pronounced in the lower limbs, interfering not only in the ability to execute 
certain activities such as rising from a chair or bed, but also in maintaining 
posture, gait speed and balance (Carvalho, 2004; Hughes et al., 2001; 
Schuler et al., 2004) leading to increased risk of falls (Kubo et al., 2003; 
Vandervoort, 2002). 
Furthermore, there is a difference in the decline of strength according to 
gender, being greater in women than in men. According Spirduso et al. 
(Spirduso, 2005), this difference is mainly explained by hormonal aspects, but 
also by the higher prevalence of sedentary life style among women. 
Thus, in addition to physiological changes previously described, there is 
evidence that environmental factors affect directly the decline in strength with 
aging, including low level of physical activity, poor nutrition and chronic 
disease (Skelton & Beyer, 2003). 
The development of muscle strength in this age group is fundamental, not 
only for maintaining and promoting health, but also to improve the functional 
capacity and independence of the elderly to perform the basic activities of 
daily life and hence, improving their QoL (Wong et al., 2003).  
 
Flexibility 
 
Flexibility is an intrinsic property of tissues from the musculoskeletal system 
that determines the maximum range of motion permitted by a joint or group of 
joints in a given plane, according to an axis without the occurrence of lesions 
(Spirduso, 2005).  
The loss of flexibility has been associated with aging, with a 20 to 30% 
decrease around 70 years of age in sedentary individuals (Carlson et al., 
1999). The range of motion throughout life is due to the influence of both 
endogenous factors such as age, sex, biological and physical condition, and 
from exogenous factors such as, the duration of training, temperature, degree 
of physical activity, and the presence of fatigue (Holland GJ, 2002). 
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The decline of flexibility is related to the increased density and stiffness of the 
tendons, ligaments and fascia, particularly due to changes in composition of 
collagen and elastin and an increase in tissue dehydration (Onder et al., 
2002). In addition to these factors, the decrease in physical activity level with 
aging has been associated with a reduction in joint amplitude levels, largely 
due to muscle disuse (Fatouros et al., 2002; Spirduso, 2005), to mechanical 
stress and degenerative diseases (American College of Sports, 1998). 
Wood et al.(Wood et al., 2005) found that decreased flexibility affects not only 
the functionality but also the health status of the older person. Low levels of 
joint range not only reduce the amount and nature of the movement 
performed, but can also increase the likelihood of damage in this joint or the 
surrounding structures, due to loss of balance and joint instability (Fatouros et 
al., 2002; Kerrigan, 2003; Spirduso, 2005).  
In this sense, it is essential to maintain an adequate level of flexibility in 
elderly, as mobility, functionality and independence of older people impact in 
their QoL (Wood et al., 2005).  
Coordination  
 
Coordination is the smooth functioning of multiple body parts when executing 
a particular movement. It’s the ability to organize and enable small and large 
muscle groups to use proper muscle sequence adapted to the task (Spirduso, 
2005). This capability has a progressive decline from 40-45 years through the 
deterioration of motor representation of changes in the neuromuscular 
system, the decrease in visual ability, balance and increased joint stiffness 
(Appell, 1992).  
Reduced movement speed, movement composition differences, increased 
variability, reduced force control, and coordination difficulties are good 
examples of   changes that occur in older adults related to the control of 
movement (Ketcham et al., 2004). As adults age, the execution of movement 
becomes slower and more variable, affecting the type of activities that older 
adults can efficiently perform and often determine whether they can live 
independently (Ketcham et al., 2004).  
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One study suggested that the elderly coordinate their movements similarly to 
the youth, but controlling them differently, that might be implicated in the 
increased incidence of falls (Kubo et al., 2003). 
Besides its relation with fall risk, this ability is very important for the tasks of 
day-to-day, as movements like pushing a coat button, turn on the stove and 
even mobility are dependent on this component. Coordination is a part of most 
tasks of daily living and therefore it is essential to understand breakdowns in 
control and regulation (Scharaeder, 2011). 
According to Spirduso et al. (Spirduso, 2005) targeted and systematic 
physical activity can slow the decrease in coordination. 
 
Agility and Balance 
 
Agility can be defined as the ability of the individual to make rapid movements 
with a change of direction and meaning. This physical quality is closely linked 
to speed, strength, flexibility and coordination. According to Rikli and Jones 
(Rikli&Jones, 2001) combined speed (joining speed coordination) and 
dynamic balance (capacity maintaining postural stability while moving) is 
important for a set of tasks that require fast mobility, such as: deviate from the 
road to avoid being hit by a car or an object, enter and exit the bus in time, or 
get up to quick to answer a call, go to the toilet or watch a pot on the stove. 
Similarly, to participate in a set of safety matches recreational / sports elderly 
people required flexibility and good dynamic balance (Haywood, 2001). The 
balance information from the visual and somatosensory sensors, the central 
integration in the brain and the motor response contribute to the dynamic 
balance (Meyer, 2006).  
The maintenance and control of posture and balance while standing in static 
or dynamic conditions, are essential requirements for independence in 
carrying out many of the basic activities of life (Pajala et al., 2004). Spirduso 
et al. (Spirduso, 2005) reported that the balance is not an isolated feature, it 
requires complex changes in muscle tone and postural control system.  
Any motion, or of a segment of the body as a whole, depends on the balance 
(Pajala et al., 2004). The maintenance and control of posture and balance 
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standing are essential requirements for independence in performing a wide 
range of activities that develop over a normal day, such as: sit in a chair, 
bathing, crossing the street (Pajala et al., 2004). The balance is essential to 
avoid falls, which in turn can cause disability, pain and bone fractures, leading 
to immobility (Donat & Ozcan, 2007; Gustafson et al., 2000). 
The agility and dynamic balance decrease with aging, verifying a steeper 
decline from the 6th decade, between 60 and 70 decreases by about 20% 
and between 75 and 80 decreases by about 15%. It is estimated that the 
prevalence of complaints in the population over 65 yrs. will reach 85%, which 
may manifest as imbalance, gait deviation, unsteadiness, nausea and 
frequent falls (Meyer, 2006; Simocelli, 2003). 
According to Rikli and Jones, exercise is an important factor in maintaining 
flexibility and dynamic balance (Rikli&Jones, 2001). Literature has shown that 
physical exercise practice improves various factors relating to balance, 
developing both the proprioceptive sensitivity, decreasing the dependence of 
visual information and thereby maintaining the quality of balance regulation 
(Gauchard et al., 2001; Gustafson et al., 2000). The interventions used varied 
from more generalized exercise programs (including aerobic, flexibility and 
strength exercises) up to exercise that target more specific components of 
postural control system (Skelton, 2001). Mian et al. (Mian et al., 2007) stated 
that the multicomponent programs are more efficient to improve locomotor 
function than just one component intervention alone (strength, endurance and 
balance). 
Balance exercise improves stability and may prevent falls and reduce injuries 
related to falls (Sherrington et al., 2004). Balance exercises are especially 
important for individuals who have a history of falling or who have mobility 
problems. Research has shown that participation in-group classes such as Tai 
Chi improves balance and reduces falls risk (Gillespie et al., 2012). In addition 
to Tai Chi, balance training may involve activities that challenge gait patterns, 
such as heel-to-toe walking; increase awareness of use of the center of 
gravity for basic movements; and augment different sensorial systems 
involved in balance maintenance (Gillespie et al., 2012). 
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Body Composition 
 
The term body composition can be divided into two major components: (i) 
lean body mass, which encompasses all non-fatty body tissues, including 
skeletal, water, muscle, connective tissue, organ tissue, and teeth, and (ii) fat 
mass, including the essential fat incorporated into organs and tissues and not 
essential fat in adipose tissue (Heyward, 1996). Body composition has a 
strong genetic component, but is also influenced by environmental factors 
such as nutrition, disease and physical activity levels (Spirduso, 2005). 
Despite the decline in weight after the 7th decade, the fat continues to 
increase with age, as lean body mass is progressively replaced by fat (Kyle et 
al., 2001). The distribution of subcutaneous body fat varies according to sex, 
age, body structure and physical activity levels. In women, there is a greater 
internal fat deposit, while visceral and subcutaneous fat tends to remain 
stable. In humans, peripheral subcutaneous fat decreases with aging, and 
there is an increased fat deposition in both central and internally (Spirduso, 
2005). 
The perivisceral obesity increases gradually in men and more rapidly in 
women after menopause, and this is associated with a higher prevalence of 
cardiovascular diseases and mortality (American College of Sports, 2000; 
Patterson et al., 2004). This difference appears mainly due to hormonal 
differences. It is believed that estrogen, a hormone responsible for female 
characteristics, has a protective effect on cardiovascular disease, by 
increasing the levels of High Density Lipoprotein (HDL), reducing the 
appearance of atherosclerotic changes (Fletcher et al., 2013; Fletcher et al., 
2001; Spirduso, 2005). 
Increased visceral fat is considered one of the most important risk factors for 
cardiovascular diseases, diabetes and other metabolic problems, because of 
increased levels of circulating free fatty acids, hyperinsulinemia, insulin 
resistance, increased triglyceride synthesis and secretion of very low density 
lipoprotein (VLDL) by the liver (Ebbert & Jensen, 2013). Body mass index 
(BMI; weight in kilograms divided by height in meters squared) is the most 
widely used indicator for the assessment of the amount of body fat, despite 
not being recognized as being the most appropriate in the elderly population 
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(Beaufrere & Morio, 2000; Carvalho, 2006). Because BMI is inversely 
proportional to the square of height, even a small change in height might have 
a large effect on BMI. The change in height with age has a substantial and 
increasing effect on BMI beyond middle age. In the 60-year period from age 
20 to 80 years, BMI on average will increase by 1.5 kg/m2 for men and 2.5 
kg/m2 for women, independent of any change in weight (Horber et al., 1997). 
Therefore, the tacit assumption that BMI measures the same degree of 
obesity at all ages is incorrect. BMI values increase with age as height 
decreases, which could lead to a misinterpretation that obesity has increased 
(Horber et al., 1997). On the other way, the age-related decline in lean mass 
contributes to a relative decrease in body weight, without a consequent 
reduction in risk associated with co-morbidities, which are thus 
underestimated (Heyward, 1996). 
Sarcopenia has been recognized as a cause of loss of functional mobility in 
elderly subjects (Evans, 1999). However, Visser et al. (Visser et al., 2005) 
reported that adiposity is more associated with functional impairment than the 
reduction in muscle mass. For example, according to these authors the 
limitations imposed by obesity in joint mobility have a greater effect on 
physical limitations, not comparable with reduced mobility due to decreased 
muscle mass. Furthermore, it is known that overweight and visceral obesity 
are particularly associated with arterial hypertension, insulin resistance, and 
dyslipidemia, increasing the risk for cardiovascular and cerebrovascular 
disorders (Patterson et al., 2004). 
Furthermore, there is a prominent role for the decreased body water reserve 
and for the bone loss. Bone mineral density is the result of a dynamic process 
of formation and reabsorption of bone and remodeling. The reabsorption 
causes deterioration of bone tissue while the formation is responsible for the 
reconstruction and strengthening of damaged tissue. This process occurs 
throughout life in cycles of 4 to 6 months duration. As a result of this dynamic 
process, the maximum bone mass is, usually, attained in the third or fourth 
decade of life (Bouchard, 1993). From there, there is a progressive decline in 
bone mineral density that can progress to osteopenia and osteoporosis 
(Demontiero et al., 2012). The amount of water in the body also undergoes 
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changes as people age, reaching 45% of the total body mass, while in the 
younger adults water counts as 60% (Sardinha et al., 2000).  
 
Adipose tissue as an endocrine organ 
 
The traditional view of adipose tissue as a passive reservoir for energy 
storage is no longer valid. Visceral adipose tissue is more involved in the 
development of metabolic diseases than subcutaneous adipose tissue 
(Kershaw & Flier, 2004). 
The major role of subcutaneous and visceral white adipose tissue is to supply 
and store energy via adipocytes. Most of the ingested excess energy is stored 
within adipocytes in the form of triglycerides, which are formed through the 
binding of glycerol and fatty acids (Kershaw & Flier, 2004). During exercise, 
cathecolamines (adrenaline and noradrenaline) secreted from the adrenal 
medulla or the sympathetic nerve terminal break down triglycerides within 
adipocytes, and the resultant fatty acids are carried to skeletal muscle via the 
blood (Sakurai et al., 2013).  
Adipose tissue is now known to express and secrete a variety of bioactive 
peptides, known as adipokines, which act at both the local 
(autocrine/paracrine) and systemic (endocrine) level. Adipokines include 
hormones such as leptin, adiponectin, and inflammatory cytokines, including 
tumor necrosis factor alpha (TNF-α), and plasminogen activator protein (PAI). 
Multiple roles in metabolic and inflammatory responses have been assigned 
to adipokines that firmly established adipose tissue as an endocrine organ 
(Gulcelik et al., 2013).  
The important endocrine function of adipose tissue is emphasized by the 
adverse metabolic consequences of adipose tissue excess. Obesity, 
particularly in the visceral compartment, is associated with insulin resistance, 
hyperglycemia, dyslipidemia, hypertension, and prothrombotic and pro-
inflammatory states (Grundy et al., 2004). Thus, excess of adipose tissue 
have harmful metabolic consequences and represent significant medical and 
socioeconomic burdens in the world today (Prentice, 2006).  
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Physiological role of adipokines 
Leptin  
Leptin is primarily made in adipose tissue and its circulating levels correlate in 
direct proportion to adipose tissue mass as well as nutritional status (Gulcelik 
et al., 2013). Physiologically, leptin is involved in regulating energy balance 
through central actions, which is of importance particularly in a context of fat 
accumulation and metabolic disorders. 
It is one of the best-known hormone markers for obesity and is very sensitive 
to levels of energy intake, particularly in energy deficient states. Two or three 
days of fasting can lower human plasma leptin levels even before any loss in 
body fat mass occurs (Margetic et al., 2002). Leptin deficiency in animals and 
humans results in increased food intake, decreased energy expenditure, and 
infertility (Friedman & Halaas, 1998). In spite of the appetite-lowering effects 
of leptin, the majority of obese individuals show hyperleptinemia (Flier, 2004). 
Persistent chronic inflammation and increased level of TNF-α may also play a 
role in hyperleptinemia of obese individuals as a positive correlation has been 
shown between TNF-α and leptin levels in both human and rodents (Flier, 
2004). 
Resistin  
Resistin, an important cysteine rich adipokine, is  evident in causing insulin 
resistance. Its expression increases during adipocyte differentiation  and the 
protein levels are high in case of obesity (Steppan et al., 2001). It is mainly 
secreted by inflammatory cells in humans being associated with the presence 
of atherosclerosis (Reilly et al., 2005; Verma et al., 2003). Prospective data on 
the association between resistin levels and cardiovascular disease events are 
increasing with conflicting results (Pischon et al., 2005; Yaturu et al., 2006). 
Although a great deal of controversy surrounds its exact biological functions in 
humans, recent studies suggest that resistin directly causes endothelial 
dysfunction. In clinical studies, resistin has been shown to be a predictive 
factor for coronary artery disease and cardiovascular disease-related 
mortality. Furthermore, resistin appears to be involved in angiogenesis, 
thrombosis and vascular smooth muscle cell migration and proliferation, all of 
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which contribute to atherosclerosis. One previous study within the Health 
Aging, and Body Composition Study (Health ABC Study) has shown an 
association between resistin levels and heart failure events in the elderly 
population (Butler et al., 2009). Moreover, a recent meta-analysis including 7 
studies reported that circulating resistin levels were associated with mortality, 
especially in high-risk individuals, such as patients with diabetes (Fontana et 
al., 2015).   
Adiponectin  
Adiponectin is an adipokine abundantly produced and secreted by adipose 
tissues and widely recognized for its antidiabetic, anti-inflammatory, 
antiatherogenic, and cardioprotective effects, with higher expression in 
subcutaneous than visceral adipose tissue (Scherer et al., 1995). Body 
composition changes with ageing can influence the adiponectin concentration. 
In older individuals, age 65 years or more, lower adiponectin levels are 
associated with higher mortality. Dysregulation of adiponectin in older persons 
may be due to loss of function of circulating adiponectin or a response to 
increased inflammatory process (Gulcelik et al., 2013). As opposed to other 
adipocytokines, the plasma levels of adiponectin inversely correlates with 
body mass index (BMI), intra-abdominal fat, and indices of insulin resistance 
(Chandran et al., 2003). Plasma levels of adiponectin decrease with weight 
gain and are increased by weight loss (Chandran et al., 2003). Several 
studies confirmed an inverse relationship between insulin resistance and type 
II diabetes with plasma adiponectin levels (Chandran et al., 2003). 
Adiponectin also reduces the progression of atherosclerosis by decreasing 
the expression of adhesion molecules, reducing proliferation of vascular 
smooth muscle, and blocking transformation of macrophages to foam cells 
(Diez & Iglesias, 2003; Kershaw & Flier, 2004). 
 
Plasminogen Activator Inhibitor-1 (PAI-1) 
 
Several proteins of the hemostasis and fibrinolytic system are secreted by 
adipocytes including tissue factor and PAI-1. PAI-1 is a member of the serine 
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protease inhibitor family and is the primary inhibitor of fibrinolysis by 
inactivating urokinase-type and tissue-type plasminogen activator (Kershaw & 
Flier, 2004). PAI-1 has also been implicated in variety of other biological 
processes including angiogenesis and atherogenesis (Juhan-Vague et al., 
2003). PAI-1 expression and secretion are greater in visceral relative to 
subcutaneus adipose tissue (Juhan-Vague et al., 2003). 
Plasma PAI-1 levels are elevated in obese and insulin resistance subjects, 
are positively correlated with features of the metabolic syndrome, and predict 
future risk for type 2 diabetes and cardiovascular disease (Juhan-Vague et al., 
2003).  
Plasma PAI-1 levels are strongly associated with visceral adiposity, which is 
independent of other variables including insulin sensitivity, total adipose tissue 
mass, or age (Juhan-Vague et al., 2003). Weight loss and improvement in 
insulin sensitivity due to treatment with metformin or thiazoladinediones 
significantly reduce circulating PAI-1 levels (Kershaw & Flier, 2004). PAI-1 
expression is upregulated by cytokines, namely by TNF-α observed in obesity 
and insulin resistance (Juhan-Vague et al., 2003),  
The excess of adipose tissue increases the production of PAI-1, leading to an 
impairment of the fibrinolytic system (Mavri et al., 2001). Moreover, obesity is 
currently considered a low-grade inflammatory state (Yudkin et al., 2000), and 
is responsible for a series of inflammatory cytokines (in particular, IL-6 and 
TNF-α able to induce the PAI-1 overexpression (Kern et al., 1995). 
 
Tumor Necrosis Factor (TNF- α)  
TNF-α is a cytokine that is mainly produced by monocytes and macrophages 
with important functions in homeostasis and disease pathogenesis. It is also 
secreted by other immunogenic cells such as CD4 lymphocytes and natural 
killer cells and plays major roles in cell death (apoptosis), inflammation, and 
induction of acute phase reactants (Kern et al., 1995). In obese individuals, 
macrophage-infiltrated visceral fat is the main site of TNF-α production. 
Expression levels of the TNF gene are higher in abdominal adipose tissue 
compared to subcutaneous fat, and, importantly, greater TNF gene 
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expression occurs in the adipose tissues of obese animals and humans (Kern 
et al., 1995). 
Accumulating data suggests a direct relationship between TNF-α plasma 
levels and insulin resistance (Hivert et al., 2008; Ruan & Lodish, 2003). Also, 
based on a community-based cohort study, it is proposed that the prevalence 
of insulin resistance increases with greater levels of resistin and TNF-α and is 
inversely related to adiponectin levels (Ruan & Lodish, 2003). Diabetic 
patients have high activity of TNF-α in the plasma and skeletal muscles 
(Hivert et al., 2008; Kershaw & Flier, 2004; Ruan & Lodish, 2003). 
 
Adipokines and aging  
Aging is associated with fat redistribution, which is characterized by loss of 
peripheral subcutaneous fat and accumulation of central fat. Individuals with 
excess adiposity, especially visceral adiposity, have dysregulation of many 
adipokines, including overproduction of TNF-alfa, IL-6, PAI-1, resistin and 
leptin, as well as downregulation of adiponectin (Arai et al., 2011). This leads 
to systemic inflammation and insulin resistance, resulting in cardiovascular 
morbidity (Ahima, 2009). On the other hand, loss of adipose tissue 
(lipodistrophy) with aging also causes adipokine dysregulation and insulin 
resistance (Caso et al., 2013). Interesting that experimental evidence has 
shown that cellular senescence of adipose tissue also stimulates the 
inflammatory cascade and causes insulin resistance (Minamino et al., 2009). 
These findings suggest that older people are susceptible to adipokine 
dysregulation caused by visceral obesity and/or lypodistrophy of peripheral 
subcutaneous fat, and that adipokine dysregulation is aggravated with 
advancing age (Arai et al., 2008). The redistribution of lipid, particularly 
infiltration into muscle, is associated with motor impairment and declining of 
physical function in older adults (Beavers, Beavers, et al., 2013). In contrast, 
centenarians may have healthy functioning adipose tissue that contains few 
macrophages, and secretes high levels of adiponectin, and low levels of 
leptin, maintaining glucose homeostasis and insulin sensitivity (Arai et al., 
2011). 
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Exercise and Aging 
 
Live an independent and autonomous life, with the ability to carry out the 
basic tasks of daily life, is a crucial aspect for maintaining quality of life for the 
elderly. However, as stated before, a condition for allowing autonomy of the 
elderly is to maintain their physical fitness and health (Narici & Maffulli, 2010).  
Physical activity seems to be an important strategy for maintaining autonomy, 
improving functional capacity, decreasing the risk of non-communicable 
chronic disease and, consequently, improving quality of life (Cerullo et al., 
2012; Narici & Maffulli, 2010). 
The sedentary lifestyle is a major contributor to the leading causes of death 
worldwide. Physical inactivity speeds up the aging process, whereas 
increased physical activity slows it down (WHO, 2014). With aging, there is an 
increased fatigability, muscle weakness and decreased endurance capacity, 
and muscle wasting, leading to decreased physical activity, and eventually to 
disease (Stewart, 2005). Figure 1 shows that, in the other way round, the 
decreased physical activity also contribute to the decrease in physical fitness 
of older adults (Stewart, 2005). 
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Figure 1. Aging, physical inactivity and disease. 
 
Effect of exercise on physical fitness and health of older persons 
 
Physical activity in general, and exercise in particular benefits people of all 
ages and may decrease all-cause morbidity and increase lifespan (Table 1) 
(King & Guralnik, 2010). In addition to decreased mortality, physical activity 
and exercise are associated with a greater likelihood of healthy aging (survival 
with better physical and cognitive functioning) (Hamer et al., 2014). For older 
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adults, the benefits of increasing physical activity include (Nelson et al., 
2007): improved conditioning and overall physical fitness; improved mobility 
and reduced onset of mobility-related disability; reduced risk of cardiovascular 
disease, thromboembolic stroke, hypertension, type 2 diabetes, osteoporosis, 
obesity, colon cancer, breast cancer, anxiety, depression, and cognitive 
decline; reduced likelihood of falls and fall-related injuries; possible decreased 
the incidence and severity of functional limitations; improved patient outcomes 
in several chronic conditions, including mood disorders, chronic pain, 
congestive heart failure, stroke, constipation, and sleep disorders. 
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Table 1. Evidence for health and physical fitness benefits associated 
with regular exercise.   
Adapted from King, 2010 (King & Guralnik, 2010). 
Adults and older adults 
Strong evidence 
Lower risk of early death 
Lower risk of coronary heart disease 
Lower risk of stroke 
Lower risk of high blood pressure 
Lower risk of adverse blood lipid profile 
Lower risk of type 2 diabetes 
Lower risk of metabolic syndrome 
Lower risk of colon cancer 
Lower risk of breast cancer 
Prevention of weight gain 
Weight loss, particularly when combined with reduced calorie intake 
Improved cardiorespiratory and muscular fitness 
Prevention of falls 
Reduced depression 
Better cognitive function (for older adults) 
Moderate to strong evidence 
Better functional health (for older adults) 
Reduced abdominal obesity 
Moderate evidence 
Lower risk of hip fracture 
Lower risk of lung cancer 
Lower risk of endometrial cancer 
Weight maintenance after weight loss 
Increased bone density 
Improved sleep quality 
 
Physical activity and exercise also limits the impact of secondary aging 
through restoration of functional capacity in previously sedentary older adults. 
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Regular exercise increases average life expectancy through its influence on 
chronic disease development, through the mitigation of age-related biological 
changes and their associated effects on health and well-being, and through 
the preservation of functional capacity (American College of Sports et al., 
2009). Moreover, some prophylactic effects of exercise in body composition 
has been described, namely in minimizing the decrease in bone mineral 
density and muscle mass and attenuate the age-related increased in total and 
visceral fat.  
 
Effect of Exercise on Adipokine levels   
Exercise, as stated before, is believed to extend lifespan by reducing the 
incidence of cardiovascular and other degenerative diseases and increases 
functional performance in older individuals (American College of Sports et al., 
2009). In opposition, an inactive lifestyle leads to the accumulation of visceral 
fat, and this is accompanied by an increased release of adipokines and the 
development of low-grade systemic inflammatory state. And this low-grade 
systemic inflammation has, in turn, been associated with the development of 
cardiovascular diseases and insulin resistance (Gleeson et al., 2011). 
Exercise has anti-inflammatory effects, and therefore, in the long-term, can 
protect against the development of chronic diseases (Pedersen & Saltin, 
2006). 
A physically active life-style has a protective effect against chronic 
inflammation associated diseases, such as CVD. This is denominated an anti-
inflammatory effect of exercise that is mediated by the reduction in visceral fat 
with a subsequent decreased production and release of inflammatory proteins 
(Gleeson et al., 2011).  
Exercise increases energy expenditure and burns off some body fat, reducing 
the risk of developing obesity and excessive adiposity, however the protective 
effect of a physically active life-style against chronic inflammation-associated 
diseases may additionally be ascribed to an anti-inflammatory effect of 
exercise. Figure 2 shows selected physiologic effects of some pro-
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inflammatory and anti-inflammatory adipokines and the effect of exercise on 
their blood levels (Golbidi & Laher, 2014). 
Figure 2. Physiologic effects of adipokines and the effect of exercise on 
their blood levels (Golbidi & Laher, 2014) 
 
 
Many believe that the beneficial effect of exercise in health is partly mediated 
through changes in the adipokines profile, that is, by increasing anti-
inflammatory cytokines and decreasing pro-inflammatory ones (Petersen & 
Pedersen, 2005). For instance, exercise increases insulin sensitivity through 
reduction of resting levels of TNF-α and CRP and augmentation of 
adiponectin levels (Golbidi & Laher, 2014).  
Circulating leptin is correlated to changes in adiposity, and exercise training–
induced decreases in adiposity result in decreased circulating leptin in both 
rodents and humans (Bouassida et al., 2010). Although this correlation 
between adipose tissue mass and leptin has been very well established, the 
role of exercise training on adipose tissue depot–specific expression of leptin 
is unclear.  
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A large body of evidence shows an inverse relationship between plasma 
levels of pro-inflammatory cytokine TNF-α and exercise training, in several 
studies in humans and animals (Golbidi & Laher, 2014). The association 
between the metabolic syndrome and inflammation is well documented 
(Welsh et al., 2010). Controlling the release and activity of TNF-α could 
contribute to the natural protective effects of physical activity in the metabolic 
syndrome, as exercise reduces CRP, IL-6, and TNF-α levels and increases 
anti-inflammatory substances such as IL-4 and IL-10 (Fallon et al., 2001).  
There is not very robust data about the impact of aerobic training in adipokine 
levels on older persons independent of the weight loss intervention. Table 2 
describes several studies with adipokines and aerobic training in older 
individuals. It can be observed that there is no strong evidence for a 
hypothesis that aerobic exercise might decrease leptin, resistin and TNF-α 
levels, or increase adiponectin levels in older individuals. However, 
importantly it should be considered that these are small sample size and 
heterogeneous studies, underpowered to drive definitive conclusions.  
Table 2. Aerobic training and adipokines in older persons. 
STUDY SAMPLE SIZE INTERVENTION RESULTS 
Coker et al, 2009 
(Coker et al., 
2009) 
N=18 (65-90), 
overweight or 
obese subjects 
 
Randomized 
12 weeks (4-5x/week) 
N=6 (high intensity, 75% 
VO2peak ) 
N=6 (moderate intensity, 
50% VO2 peak) 
N=6 control group 
No decrease in adiponectin 
levels for all groups, besides 
reduction of visceral fat in HI 
group 
Friedenreich et 
al, 2011 
(Friedenreich et 
al., 2011) 
N=320 women 
(60-66), sedentary 
 
Randomized 
12 months (5x/week, 45 
min, 3 supervised 
sessions) 
 
Assessment baseline, 6 
and 12months 
Decreased leptin but no 
changes in adiponectin 
Jorge et al, 2011 
(Jorge et al., 
2011) 
N= 48 (median 
age 54), DM type 
2 
 
Randomized 
12 weeks (3x/week, 60min 
n=12 (resistance group) 
n=12 (aerobic group) 
n=12 (combined) 
n=12 (control group) 
 
Assessment baseline and 
12 weeks 
NS differences in adiponectin, 
visfatin, resistin, TNF-α, IL et 
CRP from baseline for all 
groups 
 
Although causal mechanisms by which weight loss contributes to 
improvement in the inflammatory profile have not been fully elucidated, it is 
likely that reduction in excess adipose tissue plays a role. Individuals with 
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more adipose tissue have higher systemic levels of inflammatory biomarkers 
(Nicklas et al., 2005). There are numerous reports on changes in adipokine 
concentrations with diet in obese individuals, but studies that combined weight 
loss intervention with aerobic exercise for older adults are scarce and have no 
convincing results. These studies demonstrated a decreased (Beavers, 
Ambrosius, et al., 2013) or no decreased (Giannopoulou et al., 2005) on 
levels of leptin, and no concomitant changes in adiponectin, resistin, and 
TNF-α levels in obese older adults (Beavers, Ambrosius, et al., 2013; Ryan et 
al., 2003) and postmenopausal women with type 2 diabetes (Giannopoulou et 
al., 2005).  
Table 3 describes studies of adipokines in older persons and resistance 
training program. TNF-α levels were not affected in all these studies 
(Bautmans et al., 2005; Bruunsgaard et al., 2004; Prestes et al., 2009; 
Reynolds et al., 2004). Of interested, decreased levels of leptin and resistin, 
and increased levels of adiponectin were demonstrated (Botero et al., 2013; 
Fatouros et al., 2005; Prestes et al., 2009). The weight loss intervention 
contributed to the decreased levels of leptin after resistance training (Ryan et 
al., 2000). 
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Table 3. Resistance training and adipokines in older persons 
STUDY SAMPLE SIZE INTERVENTION RESULTS 
Ryan et al, 
2000 (Ryan 
et al., 2000) 
 
N=15 women (50-
69 years-old) 
16 weeks (3x/week) 
n=8RT  
n=7RT+weight loss 
NS differences in leptin 
levels on RT but 
significant changes in 
RT+weight loss 
Reynolds et 
al, 2004 
(Reynolds et 
al., 2004) 
N=11 (median 
age=67) 
4 months (3x/week) 
8 exercises ; 2 sets ; 10-
12 reps 
NS change in TNF-α 
Bruunsgaard 
et al, 2004 
(Bruunsgaard 
et al., 2004) 
n= 23 elderly men 
and women 
 
12 weeks 
n=11  (3x/week, 50-80% of 
1RM) and  
n=12 (control group) 
 
Assessments week 0 and 
week 12 
TNF-α NS 
Bautmans et 
al, 2005 
(Bautmans et 
al., 2005) 
N=31 (median 
age=68) 
6 weeks (3x/week) 
6 exercises; 3 sets; 10 
reps (50-80% 1RM) 
NS changes in TNF-α 
Fatouros et 
al, 2005 
(Fatouros et 
al., 2005) 
n=50  elderly, 
overweight and 
sedentary men 
 
Randomized 
n=10 (control) 
 n=14 (RT 45 -50% 1RM) 
 n=12 (RT 60-65% 1RM) 
 n=14 (RT 80-85% 1RM) 
 
6 months (3x/week) and 6 
months of  detraining 
 
Assessments month 0 and 
6, and end of detraining 
period 
Decreased leptin levels 
in all groups 
 
Increased 
adiponectin levels only in 
high intensity group 
 
 
Prestes et al, 
2009 
(Prestes et 
al., 2009) 
N=35 women 
(mean age 63 
years) 
16 weeks (2x/week, 6-
14RM) 
Assessment baseline and 
after 24 and 48 hours 
TNF-α NS, decreased 
leptin 
Botero et al, 
2013 (Botero 
et al., 2013) 
N=23 (median 
age=63) 
12 months (2x/week, 3 
sets of 6-14 RM) 
 
Assessment baseline and 
12 months 
Decreased leptin and 
resistin levels 
 
Table 4 describes studies of adipokines with combined aerobic and resistance 
training programs in older persons.  A limited number of studies have 
evaluated the impact of combined resistance and aerobic training in adipokine 
levels of older adults. Two longitudinal studies have demonstrated increased 
adiponectin levels after 12 and 16 weeks combined resistance and aerobic 
training in healthy (Markofski et al., 2014) and diabetic (Brooks et al., 2007) 
older subjects. However, currently, studies have not demonstrated a benefit of 
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concurrent training in leptin (Gondim et al., 2015; Ligibel et al., 2009), resistin 
(Gondim et al., 2015; Jorge et al., 2011) and TNF-α levels (Beavers, Hsu, et 
al., 2010; Gondim et al., 2015; Jorge et al., 2011). Overall, the described 
results have not shown that combined training had an impact upon levels of 
adipokines, except for the increased adiponectin levels in two studies (Brooks 
et al., 2007; Markofski et al., 2014) and decreased leptin and resistin levels in 
the overweight and obese groups (Gondim et al., 2015). The heterogeneity of 
these studies, the small samples sizes and lack of control in dietary intake 
and habitual daily physical activity makes it difficult to draw firm conclusions 
regarding the impact of exercise on adipokine levels.  
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Table 4. Resistance plus aerobic training and adipokines in older 
persons 
STUDY SAMPLE SIZE INTERVENTION RESULTS AND COMMENTS 
Brooks et 
al, 2007 
(Brooks et 
al., 2007) 
n=62 (median 
age 62 years 
old), DM type 2 
16 wks 
n=31 PA 
n=31 (control group) 
Increased adiponectin levels 
with PA 
Ligibel et 
al, 2009 
(Ligibel et 
al., 2009) 
n= 81 
overweight 
sedentary BC 
survivors 
16 wks 
n=51 (PA group) 
n=49 (control group) 
 
Assessment baseline and 
16wks 
Adiponectin and leptin NS 
 
Supervised strength (2x/week) 
and home-based aerobic 
training (90min/ week) 
Beavers et 
al, 2010 
(Beavers, 
Brinkley, et 
al., 2010) 
n=424 (70-89), 
SPPB <10, 
sedentary 
lifestyle 
 
Randomized 
 
 
12 mo 
n= 182 (combined PA 
group) 
n= 186 (active 
control=health education)  
 
Assessment baseline, 6 
mo and 12 mo 
NS changes in TNF-α and 
adiponectin, decreased IL-8 
 
PA progressive transition from 
supervision to home based. 
Markofski 
et al, 2014 
(Markofski 
et al., 
2014) 
n=29 (65-85), 
older, healthy 
 
longitudinal 
study 
12 wks (3x/week),  
60-70% HR, 80% 1RM 
and weekly increased 
resistance 5-10%) 
 
Increased adiponectin and 
ghrelin, and NS decreased 
leptin, no significant changes 
in body composition. 
Gondim et 
al, 2015 
(Gondim et 
al., 2015) 
n=143 (median 
age 56) 
12 mo (60min, 2x/week), 
swimming and/or water 
aerobics interspersed with 
resistance training 
 
n= 32 (normal weight 
group) 
n= 59 (overweight group) 
n= 52 (obese group) 
 
Assessment baseline, 
6mo and 12mo 
No effect in adipokine levels 
(leptin, adiponectin, resistin, 
IL-6 and TNF-α) for normal 
weight group. 
 
Leptin, resistin, IL-6 levels 
were decreased in overweight 
and obese groups. 
Jorge et al, 
2011 
(Jorge et 
al., 2011) 
n= 48 (median 
age 54), DM 
type 2 
 
Randomized 
12 wks (3x/week, 60min 
n=12 (resistance group) 
n=12 (aerobic group) 
n=12 (combined) 
n=12 (control group) 
 
Assessment baseline and 
12 wks 
NS differences in adiponectin, 
visfatin, resistin, TNF-α, IL et 
CRP for all groups 
SPPB: Short Physical Performance Battery score; BC: breast cancer: DM: diabetes mellitus; 
NS: non-significant. 
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Aerobic exercise in older persons  
Aerobic exercise involves the use of large muscle groups and must be 
sustained for a minimum of 10 minutes (American College of Sports et al., 
2009). Examples of aerobic activities include brisk walking, jogging, 
swimming, water aerobics, tennis, , dancing, bicycle riding, and use of 
"cardio" equipment (eg, elliptical machines, stair climbing machines, 
stationary bicycles, and treadmills) (American College of Sports et al., 2009). 
Guidelines from the AHA and the ACSM suggest a minimum of 150-
300min/week of moderate-intensity aerobic activity or a minimum of 75-
150min/week of vigorous-intensity activity, or some combination of the two 
(American College of Sports et al., 2009). The recommended guidelines for 
aerobic activities are considered to be in addition to self-care activities 
normally conducted throughout the day such as cleaning, bathing, walking to 
the car, or doing errands. Definitions for moderate and vigorous activity 
depend on the person's baseline conditioning, and are based on a perceived 
relative exertion of effort (American College of Sports et al., 2009). Regular 
exercise, particularly dynamic exercise of moderate intensity (≤ 70% of 
VO2max or ≤80% of maximum heart rate) involving mostly the aerobic energy 
pathway and large muscle mass (e.g., walking, bicycling) attenuates age 
declines in cardiorespiratory fitness (American College of Sports et al., 2009). 
This type of exercise, commonly referred as ‘‘aerobic exercise’’ (or 
‘‘endurance exercise’’), has a restoring effect on several important risk factors 
of cardiovascular disease, such as, endothelial dysfunction (DeSouza et al., 
2000; Walsh et al., 2003). Importantly, aerobic exercise training has a 
beneficial dose–response effect in attenuating aging autonomic system 
dysfunction, with trained elderly individuals showing similar baroreflex function 
compared with their moderately active younger peers (Monahan et al., 2000). 
Heart rate variability (HRV) is a marker of autonomic function and a powerful 
predictor of cardiovascular disease outcome (high HRV is associated with a 
better prognosis), and increases with aerobic exercise training in older people 
(Nolan et al., 2008). 
Supervised aerobic endurance training (AET) programs of sufficient intensity 
(≥60% of pre-training VO2max), frequency (≥3 d/wk), and length (≥16 wk) can 
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significantly increase maximal aerobic capacity measured by maximum 
volume of oxygen (VO2max) in healthy middle-aged and older adults. The 
average increase in VO2max reported in well-controlled studies lasting 16 to 
20 weeks is 16.3% when compared with non-exercise control subjects during 
the same period. Larger improvements in VO2max are typically observed with 
longer training periods (20 to 30 wks.) but not necessarily with higher training 
intensities (Huang, Gibson, et al., 2005), unless an interval-type training 
regimen is used (Ahmaidi et al., 1998; Makrides et al., 1990). Significant AET 
increases in VO2max have also been reported in healthy subjects older than 
75 years, but the magnitude of improvement is significantly less (Evans, 2000; 
Malbut et al., 2002). Although men and women in their 60’s and early 70’s 
show similarly relative (% above pre-training) increases in VO2max after AET 
compared with younger adults (Spina, 1999).  
Three or more months of moderate-intensity AET elicits several 
cardiovascular adaptations in healthy middle-aged and older adults, which are 
evident at rest and in response to acute dynamic exercise. The most 
consistently reported adaptations include the following: 1) a lower heart rate 
(HR) at rest (Huang, Shi, et al., 2005) and at any submaximal exercise 
workload (Hagberg et al., 1989); 2) smaller rises in systolic, diastolic, and 
mean blood pressures during submaximal exercise (Seals et al., 1984); 3) 
improvements in the vasodilator and O2 uptake capacities of the trained 
muscle groups (Jubrias et al., 2001; Wray et al., 2006); and 4) numerous 
cardio protective effects, including reductions in atherogenic risk factors 
(reduced triglyceride and increased HDL concentrations), and reductions in 
large elastic artery stiffness (Tanaka et al., 2000).  Moreover, in studies 
involving overweight middle-aged and older adults, moderate-intensity AET 
without dietary modification has generally been shown to be effective in 
reducing total body fat (Kay & Fiatarone Singh, 2006; Toth et al., 1999).  
The ACSM (American College of Sports et al., 2009) indicates aerobic 
exercise in older people as an effective strategy to increase functional 
independence and decrease the prevalence of many diseases associated 
with aging. Older people who start a training program can expect 
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improvements in VO2max between 10% and 30%, depending on the intensity 
and duration of training (American College of Sports, 1998). Besides the 
improvements in VO2max with aerobic exercise, when the activity involves the 
use of rhythmical large muscle groups for longer periods, some studies have 
shown that muscle endurance work also seems to favor the aerobic fitness, 
not only by increasing muscle mass but also by increasing the capillarity and 
muscle oxygenation (Spirduso, 2005). So, muscular endurance stimulus is 
indicated as an adjunct to endurance work (Kenny et al., 2008).   
Resistance Training in older persons  
 
Several studies have shown that elderly patients may improve muscle 
strength with training, particularly with resistance training (Hruda et al., 2003; 
O'Neill, 2000), regardless of high or low frequency and intensity used 
(Izquierdo et al., 2004). 
Activities to maintain and increase muscle strength include weight training, 
weight bearing, or resistance training (RT). Development of muscle strength 
and muscle endurance is progressive and requires gradual increases in 
strengthening activities over time. Muscle-strengthening activities should be 
done a minimum of two non-consecutive days of the week and should target 8 
to 10 major muscle groups (abdomen, bilateral arms, legs, shoulders, and 
hips). There is no recommended time for muscle-strengthening activities; 
individuals should strive to perform 10 to 15 repetitions of each exercise at a 
moderate to high level of intensity and gradually increase resistance over time 
(Faigenbaum et al., 2009). Training programs, especially if including 
resistance (strength) exercises (i.e., movements, such as weightlifting or 
exercises with resistance bands, performed against a specific external force 
that is regularly increased during training) are especially useful for improving 
muscle mass and/or strength in the elderly (Liu & Latham, 2009). In general, 
data of RT interventions in older persons had a duration ranging from 4 to 48 
weeks and were in agreement with accepted or ‘‘traditional’’ exercise 
recommendations for older people, with the usual weekly schedule including 
two to three nonconsecutive sessions with one to three sets of 10–15 
repetitions of classic weightlifting exercises, such as leg press (Nelson et al., 
 54 
2007).  
Other effective interventions in older population include ‘‘high-velocity 
resistance training,’’ i.e., focusing on speed of movement (Earles et al., 2001; 
Evans, 2003), or even explosive-type heavy-resistance training, e.g., 
weightlifting exercises with a load equivalent to 75%–80% of one repetition 
maximum (1RM) and performed with maximal intentional acceleration of the 
training load during the concentric movement phase (Caserotti et al., 2008). In 
general, besides being feasible and well tolerated even by the oldest old, this 
alternative type of intervention would elicit similar (Sayers et al., 2003) or even 
higher improvements in functional performance and disability compared with 
more traditional, lower-velocity resistance training (Fielding et al., 2002).  
Combined and concurrent training in older persons   
A combination of aerobic and resistance activities seems to be more effective 
than either form of training alone in counteracting the detrimental effects of a 
sedentary lifestyle on the health and functioning of the cardiovascular system 
and skeletal muscles (American College of Sports et al., 2009). Regular 
combined exercise also reduces the risk of chronic metabolic and 
cardiovascular diseases because it exerts anti-inflammatory effects, mediated 
via both by a reduction in visceral fat mass and the induction of an anti-
inflammatory environment (Gleeson et al., 2011).  
Resistance and aerobic training promote specific neuromuscular and 
cardiovascular adaptations. The muscle hypertrophy and increased motor unit 
recruitment capacity induced by strength training result in improved muscle 
strength and power development (Peterson et al., 2010). In contrast, aerobic 
training induces central and peripheral adaptations that improve the 
cardiovascular function (Cadore et al., 2014). The combination of resistance 
and aerobic training in older persons was demonstrated to enhance 
respectively, by 20%–30% the cardiorespiratory capacity and muscle strength 
in older adults (Huang, Gibson, et al., 2005; Lemmer et al., 2000). 
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However, some studies have been shown the “interference effect”, a 
phenomenon that occurs when pairing endurance and strength training 
together, one right after the other (concurrent training) (Chtara et al., 2005; 
Chtara et al., 2008). In this phenomenon, training induces lower strength 
gains when compared to resistance training alone (Docherty & Sporer, 2000). 
With the limited number of studies that have investigated the concurrent 
training adaptations in older age (Cadore et al., 2012; Cadore et al., 2011; 
Izquierdo et al., 2004), it seems relevant to identify the most effective 
combination of training variables (i.e., volume, intensity, weekly frequency, 
exercise-order), to optimize the concurrent training prescription in older 
persons (Cadore et al., 2014). 
In conclusion, the advantage of prescribing resistance training simultaneously 
with aerobic training is related with the improvements of both neuromuscular 
and cardiovascular functions, even when the muscle strength increases at 
lower magnitude when compared with strength training alone (Cadore et al., 
2014).  
The American College of Sports Medicine (ACSM) recommendations on the 
types and amounts of physical activity needed by healthy older adults to 
improve or maintain health includes both endurance and strength training 
(American College of Sports et al., 2009). According to the United States 
Centers for Disease Control and Prevention (CDC), ACSM and WHO, elderly 
individuals should perform muscular strength (twice a week or more, with 
involvement of most muscle groups) and aerobic activities (at least 150 min of 
moderate intensity activity or 75 min of vigorous intensity activity, or a 
combination of these per week) in order to reduce the risk of mortality from all 
causes, including coronary heart disease, stroke, hypertension, and type 2 
diabetes (Organization, 2010; States), 2008). The WHO presents the 
following summary recommendations for exercise in people aged 65 years 
and older (Organization, 2010): 
• At least 150 min of moderate-intensity aerobic activity, or at least 75 min of 
vigorous-intensity aerobic activity, or an equivalent combination. 
• Aerobic activity should be performed in bouts of at least 10 min duration. 
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• For additional health benefits, undertake up to 300 min of moderate-
intensity or 150 min of vigorous-intensity aerobic activity, or an equivalent 
combination. 
• People with poor mobility should do balance exercise to prevent falls on 3 
or more days. 
• Muscle-strengthening activities should be done on two or more days. 
• If older adults are unable to do the recommended amounts of physical 
activity due to health conditions, they should be as physically active as 
they are able.  
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Chapter 3 - Objectives of the Study    
 77 
Based on the literature synthesis described, the driven hypothesis was that a 
concurrent combined aerobic and resistance training might improve functional 
fitness parameters, adipokine plasma profile and biochemical cardiovascular 
risk factors in older adults. 
The studies included in this thesis had three main objectives:  
1. To investigate the relationships between adiponectin, leptin, lipid profile and 
body composition in older adults. 
 2. To evaluate the effects of a concurrent combined aerobic (AT) and 
resistance (RT) training in body composition, muscle strength, muscular 
endurance and cardiorespiratory fitness in older adults. 
3. To evaluate the effects of a concurrent combined aerobic (AT) and 
resistance (RT) training in plasma levels of adipokines and lipid profiles. 
 78 
The titles and objectives of each study are presented in Table 5. 
Table 5. Titles, objectives, and status of each study included in the 
thesis.  
Study I Title: Relationships Between Adiponectin, Leptin, Lipid Profile 
and Body Composition in Older Adults. 
 
Aim: To investigate the relationships of adipokines (adiponectin, 
leptin) with blood lipids and body composition parameters in 
physically inactive older adults  
Status: submitted to Aging Clinical and Experimental Research. 
Study II Title: Concurrent Training Improves Strength, Muscular 
Endurance and Flexibility in Older Adults 
Aim: To evaluate the effects of a concurrent combined aerobic 
(AT) and resistance (RT) training in body composition, muscle 
strength, muscular endurance and cardiorespiratory fitness in 
older adults (aged >60yrs) 
Status: submitted to Journal of Physical Activity & Health 
Study III Title: Effects of concurrent aerobic and resistance training on 
adipokines and lipid profile in older adults 
Aim: to investigate the effects of concurrent aerobic and 
resistance training on the plasma adipokines’ levels (PAI-1, TNF-
α, resistin, adiponectin, and leptin) and lipid profile in older adults.  
 
Status: submitted to Archives of Gerontology and Geriatrics. 
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Chapter 4 - Experimental work    
 80 
This thesis was performed at the Faculty of Sports, University of Porto, 
Portugal. The subjects were recruited from two sources: individuals from the 
local community that were on a waiting list for exercise, and those that 
became aware of the study through advertisements posted at various sites in 
the Porto area.  
Figure 3 illustrates the main methodological features of the experimental 
work, detailing for each paper, the sample size, participants’ mean age, 
outcome variables, measurement techniques and the data analyses.  
The complete description for each section is presented in the corresponding 
paper at the methods section.  
All participants provided a voluntary written consent (see appendix) and the 
ethical approval was granted by the Ethics Committee of the Faculty of Sport 
from the University of Porto. 
The following papers were included in this thesis:  
Paper I: Relationships between Adiponectin, Leptin, Lipid Profile and Body 
Composition in Older Adults 
Paper II: Concurrent Training Improves Strength, Muscular Endurance and 
Flexibility in Older Adults 
Paper III: Effects of concurrent aerobic and resistance training on adipokines 
and lipid profile in older adults 
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Figure 3- Schematic model of the experimental work design.  
 
 
 
   
Paper I Paper II Paper II 
Cross-sectional study Experimental study Experimental study 
EG: n= 18 CG: n= 16  EG: n= 18 CG: n= 16 34 older adults 
Final sample 
Mean age 
EG= 68.5±..yrs CG= 75.1±..yrs  EG= 68.5 ± ..yrs. CG= 75.1±..yrs  71.62 years Outcome variables 
Interviews Height/weight (BMI)  Lean Mass Fat Masss % of body fat Android fat mass Gynoid fat mass % of trunk fat Trunk fat mass % of android fat % of gynoid fat  Leptin Adiponectin Triglycerides Glucose Total cholesterol HDL cholesterol LDL cholesterol 
Interviews Height/weight (BMI) Lean Mass Fat Masss % of body fat  Leptin Resistin PAI-1 TNF-α Adiponectin Triglycerides Glucose Total cholesterol HDL cholesterol LDL cholesterol  Dietary intake    
Interviews Height/weight (BMI)  Lean Mass Fat Masss % of body fat  Functional fitness  Isokinetic strenght  Dietary intake          
Measurement technique 
Stadiometer and weight scala DEXA Calorimetric assay Multiplex analysis assay    
Stadiometer and weight scala DEXA Senior fitness test (Rikli&Jones, 1999) Isokinetic Dynamometer 3-day dietary record  
Stadiometer and weight scala DEXA Calorimetric assay Multiplex analysis assay  3-day dietary record  
Statistical analyses 
 
Pearson’s correlation  Stepwise multiple regression analyses     
Student’s independente test Chi-square test Repeated-measures  ANOVA Bonferroni post hoc test   
Student’s independente test Chi-square test Repeated-measures  ANOVA Bonferroni post hoc test   
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Study I 
 
Relationships between Adiponectin, Leptin, Lipid Profile and Body 
Composition in Older Adults. 
 
Submitted to Aging Clinical and Experimental Research 
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 Abstract 
 
Background: The secretion, synthesis and function of adipokines are influenced 
by the aging process. Published studies evaluating adiponectin and leptin 
levels in parallel to lipid profile and body composition demonstrated that plasma 
levels of adipokines are correlated with an atherogenic lipoprotein profile and 
body fat distribution. Aim: to investigate the relationship of adiponectin and 
leptin with blood lipids and body composition parameters in older adults.  
Methods: The relationship between anthropometrical and body composition 
parameters, adiponectin, leptin, and blood lipids were evaluated in 34 untrained 
older adults. Results: adiponectin correlated negatively with android fat mass (r 
= −0.335) and the percentage of android fat mass (r = −0.321) from the 
anthropometrical and body composition parameters. Adiponectin correlated 
positively only with HDL cholesterol (r = 0.346). Leptin correlated positively with 
body mass (r = 0.433), BMI (r = 0.666), percentage of fat mass (r = 0.847), fat 
mass (r = 0.806), android fat mass (r = 0.675), gynoid fat mass (r = 0.753), 
percentage of trunk fat (r = 0.846), trunk fat mass (r = 0.768), percentage of 
android fat (r = 0.812) and percentage of gynoid fat (r = 0.766) from the 
anthropometrical and body composition variables. Only the lean mass was not 
correlated with leptin in the body composition parameters.  
Conclusion: this study suggests that leptin is influenced by body mass and lean 
mass, and adiponectin is influenced by abdominal fat mass and HDL 
cholesterol. 
 
 
Keywords: adipokines; blood lipids; body composition; older adults 
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 Introduction 
 
Aging is accompanied by disordered lipid metabolism, with elevated cholesterol 
levels which contribute to atherosclerotic cardiovascular disease (1). Despite 
the decline in weight after the 7th decade, fat continues to accumulate with age, 
and progressively replaces lean body mass (2). The increased perivisceral 
obesity in men and in women after menopause is associated with a higher 
prevalence of and mortality from cardiovascular diseases (3, 4).  
The aging process also alters the synthesis, secretion and function of 
adipokines (5). In this context, circulating levels of leptin seems to correlate with 
adipose tissue mass as well as nutritional status. In spite of the appetite-
lowering effects of leptin, the majority of obese individuals show 
hyperleptinemia (6). Adiponectin is an adipokine with beneficial effects on fat 
metabolism and insulin sensitivity. It has been shown to improve insulin 
secretion, insulin sensitivity and fatty acid oxidation, and to have an anti-
inflammatory influence to prevent atherosclerosis (7). Its concentration seems 
to decreases with weight gain and to increase with weight loss (8). 
Currently, published studies evaluating adiponectin and leptin levels in parallel 
to lipid profile (7, 9-11) and body composition (9, 12-14) demonstrated the 
plasma levels of these adipokines to be correlated with an atherogenic 
lipoprotein profile and body fat distribution. Particularly, these studies were not 
exclusively focused on older adults. In order to contribute to a better 
understanding of the metabolic effects of these cytokines in this population, the 
aim of this study was to investigate the relationship of adipokines (adiponectin, 
leptin) with blood lipids and body composition parameters in untrained older 
adults.  
 
2. Methods 
 
2.1. Study population 
 
Untrained adults aged 60 years or older were invited to participate in this cross-
sectional study, performed at the Faculty of Sports, University of Porto, 
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 Portugal. The subjects were recruited from the local community through 
advertisements posted at various sites in the Porto area. Thirty-eight individuals 
were recruited, but four were excluded, as they did not complete baseline 
assessments. The nature, benefits, and risks of the study were explained to the 
volunteers, and their written informed consent was obtained before the study. 
The study was carried out consistently with the Declaration of Helsinki, with 
approval from the Ethics Committee and the Scientific Board from the Faculty 
of Sport, University of Porto, for all methods, protocols and procedures. The 
baseline demographic and clinical features are shown in table 1. 
 
Table 1 – Demographic and clinical baseline features 
 Group (n=34) 
 
Age (years) 
 
71.6 ± 7.3 
Female 26 (76.4) 
Obesity 6 (17.6) 
Diabetes 7 (20.5) 
Hypertension 15 (44.1) 
Ischemic Heart Disease 3 (8.8) 
Dyslipidemia 14 (41.1) 
Smoking  2 (5.8) 
Previous history of cancer 2 (5.8) 
Osteoporosis 13 (38.2) 
Thyroid disease 4 (11.7) 
Osteoarthritis 20 (58.8) 
Notes: Data for age are expressed as mean ± SD, and as  
n (%) for other variables. 
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 Biochemistry characteristics, anthropometrical parameters, and body 
composition are presented in Table 2.  
Table 2. Anthropometric, body composition and biochemistry characteristics  
at baseline 
  Mean SD N 
     
Body Mass (kg) 66.92 10.2 34 
Body Mass Index (kg.m-2) 27.60 3.5 34 
Percentage of Body Fat (%) 38.45 6.4 34 
Fat Mass (kg) 25.32 6.5 34 
Lean Mass (kg) 38.25 6.5 34 
Android Fat Mass (kg) 2.17 0.8 34 
Gynoid Fat Mass (kg) 3.75 0.9 34 
Percentage of Trunk Fat (%) 38.54 6.8 34 
Trunk Fat Mass (kg) 12.86 3.8 34 
Percentage of Android Fat (%) 40.23 7.8 34 
Percentage of Gynoid Fat (%) 38.25 5.9 34 
Leptin (ng.ml-1)* 4.32 1.9 34 
Adiponectin (ug.ml-1)* 3.38 0.8 34 
Triglycerides (mg.dL-1) 109.26 41.8 34 
Glucose (mg.dL-1)* 9.62 1.2 34 
Total Cholesterol (mg.dL-1) 206.76 35.5 34 
HDL-C (mg.dL-1) 53.70 9.9 34 
LDL-C (mg.dL-1) 131.30 30.6 34 
(*): Variables transformed for analysis (not normally distributed) 
 
 
 2.2. Measurements 
 
2.2.1. Anthropometrics 
 
Body weight was measured to the nearest 0.1 kg with an electronic weight scale 
(SECA 708). Subjects were weighed barefoot wearing light clothing. Height was 
measured to the nearest 1 mm with a standard stadiometer. Body composition 
(Percentage of Body Fat, Fat Mass, Android Fat Mass, Gynoid Fat Mass, 
Percentage of Trunk Fat, Trunk Fat Mass, Percentage of Android Fat, 
Percentage of Gynoid Fat and Lean Mass) was determined using a Dual-
energy X-ray Absorptiometry (DXA, Hologic QDR-4500, software for Windows 
XP, version 12.4) with subjects in the supine position. The same investigator 
analyzed all body scans. The principles behind body composition analyses with 
DXA are explained elsewhere (15). 
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 2.2.2. Blood Sampling and Biochemichal Analysis 
 
All blood samples were collected in Terumo Venosafe® Serum-Gel tubes in the 
early morning (between 7 and 9 AM) after a 12-hour fast at the baseline. 
Serum was separated within 30 min of blood collection, after centrifugation for 
10 min at 400x g. Aliquots of serum were stored at -80ºC until use. 
Total cholesterol, high-density lipoprotein cholesterol (HDL-C), low-density 
lipoprotein cholesterol (LDL-C), triglycerides and glucose were measured by a 
colorimetric assay, using the Olympus Diagnostics AU5400 analyser system 
(Beckman Coulter, USA).  
Adiponectin and leptin were measured by a multiplex analysis assay (Millipore, 
Hamburg, Germany). Briefly, the appropriate cytokine standards, controls and 
plasma samples were diluted in assay buffer and added to pre-wet filter plates. 
Fluorescent beads containing adiponectin and leptin antibodies were added 
and incubated on a plate shaker overnight, at 4ºC. The wells were washed, and 
the samples were incubated with detection antibodies, for 30 minutes at room 
temperature and with streptavidin-phycoerythrin, under the same conditions. 
After washing, beads were resuspended with sheath fluid and analysed on a 
Luminex 200TM. Mean fluorescent intensity data (MFI) were analysed using the 
Luminex 100 Integrated System version 2.3 (Luminex Corporation, USA).  
 
2.3. Statistical Analysis 
 
All analyses were carried out in SPSS version 21.0 for Mac OSX (SPSS Inc., 
Chicago, IL, USA), with a two-sided statistical significance set at 5%. Before 
analysis, logarithm or square root transformations of the data were performed 
to normalize skewed distributions. Associations were reported as Pearson’s 
correlation coefficients. Stepwise multiple regression analysis models were 
also used to evaluate potential associations of adiponectin and leptin with 
anthropometrical and body composition parameters and blood lipids.  
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 3. Results 
 
In Table 3, the relationship between anthropometrical and body composition 
parameters, adiponectin, leptin, and blood lipids are presented. Adiponectin 
correlated negatively with android fat mass (r = −0.335) and the percentage of 
android fat mass (r = −0.321) from the anthropometrical and body composition 
parameters. From blood lipids, adiponectin correlated positively only with HDL-
C (r = 0.346). Leptin correlated positively with body mass (r = 0.433), body mass 
index (BMI) (r = 0.666), percentage of fat mass (r = 0.847), fat mass (r = 0.806), 
android fat mass (r = 0.675), gynoid fat mass (r = 0.753), percentage of trunk 
fat (r = 0.846), trunk fat mass (r = 0.768), percentage of android fat (r = 0.812) 
and percentage of gynoid fat (r = 0.766) from the anthropometrical and body 
composition variables. Only the lean mass was not correlated with leptin in the 
body composition parameters. From blood lipids, leptin correlated positively 
with triglycerides (r = 0.311) and glucose (r = 0.303). 
 
Table 3. Pearson correlation coefficients (r) between leptin or adiponectin,  
anthropometric body composition measures and biochemistry markers 
 Leptin  Adiponectin 
r P  r P 
Anthropometric and Body 
Composition Measures 
     
Body Mass (kg) .433   .005**  −.266 .064 
Body Mass Index (kg.m-2) .666 <.001**  −.076 .334 
Percentage of Body Fat (%) .847 <.001**  −.170 .169 
Fat Mass (kg) .806 <.001**  −.233 .092 
Lean Mass (kg) −.169 .170  −.153 .195 
Android Fat Mass (kg) .675 <.001**  −.335   .026* 
Gynoid Fat Mass (kg) .753 <.001**  −.164 .177 
Percentage of Trunk Fat (%) .846 <.001**  −.258 .070 
Trunk Fat Mass (kg) .768 <.001**  −.280 .054 
Percentage of Android Fat (%) .812 <.001**  −.321   .032* 
Percentage of Gynoid Fat (%) .766 <.001**  −.037 .417 
 
Biochemistry Characteristics 
 
     
Triglycerides (mg.dL-1) .311  .037*  −.189  .142 
Glucose (mg.dL-1) .303  .041*    .074  .339 
Total Cholesterol (mg.dL-1) .085 .316  −.110  .269 
HDL-C (mg.dL-1) −.029 .435    .346   .023* 
LDL-C (mg.dL-1) .025 .443  −.189  .142 
* P<0.05; ** P<0.01 
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 Stepwise multiple regression analysis results are presented in Table 4, with the 
relationship between dependent variables (adiponectin and leptin) and 
independent variables (anthropometrical, body composition parameters and 
blood lipids). Adiponectin was positively associated only with HDL-C (P = 
0.045) from the blood lipids parameters. From body composition, adiponectin 
was negatively associated with android fat mass (P = 0.005) and positively 
associated with BMI (P = 0.035). Leptin was positively associated with body 
mass (P < 0.001) and negatively associated with lean mass (P < 0.001). In 
addition, leptin tended to be positively associated to triglycerides (P = 0.073).  
 
Table 4 - Relationship between dependent and independent variables 
  β P Value Collinearity 
VIF 
Adiponectin    
HDL-C (mg.dL-1)    0.346 0.045* 1,000 
Body Mass Index (kg.m-2)    0.605 0.035* 3,046 
Android Fat Mass (kg)  −0.831 0.005** 3,046 
Leptin    
Triglycerides (mg.dL-1)    0.311 0.073 1,000 
Body Mass (kg)    1.383 0.001** 2,458 
Lean Mass (kg)  −1.234 0.001** 2,458 
Dependent variables: Adiponectin and Leptin; Independent variables: HDL-C,  
Body Mass Index, Android Fat Mass, Triglycerides, Body Mass, and Lean Mass. 
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 Table 5 shows the final models of the linear regression of the dependent and 
independent variables. HDL-C was significantly associated with adiponectin 
concentrations in the stepwise multiple regression analysis (R2 = 0.120, P = 
0.045), as were android fat mass and body mass index (R2 = 0.233, P = 0.017). 
Lean mass and body mass were significantly associated with leptin 
concentrations (R2 = 0.807, P < 0.001), and marginally with triglycerides (R2 = 
0.097, P = 0.073). 
 
Table 5. Results from stepwise multivariate linear regression analyses with serum Adiponectine 
and Leptinf as dependent variables and potential predictors as independent variables. 
 Change Statistics  
Mode
l 
R R 
Squar
e 
Adjuste
d R  
Square 
Std. 
Error of 
Estimat
e 
R 
Square 
Change
d 
F 
Chang
e 
D
f 
1 
D
f 
2 
Sig
. F 
Durbin-
Watso
n 
1e .346
a 
.120 .092 .76339 .120 4.347 1 32 .045 1.754 
2e .482
b 
.233 .183 .72416 .233 4.696 2 31 .017 2.261 
3f .898
c 
.807 .795 .86424 .807 64.872 2 31 .000 2.022 
4f .311
d 
.097 .069 1.84075 .097 3.434 1 32 .073 2.627 
a. Predictors: (Constant), HDL-C (mg.dL-1) 
b. Predictors: (Constant), Android Fat Mass (kg), Body Mass Index (kg.m-2) 
c. Predictors: (Constant), Lean Mass (kg), Body Mass (kg) 
d. Predictors: (Constant), Triglycerides (mg.dL-1) 
e. Dependent Variable: Adiponectin (ug.ml-1) 
 f.     Dependent Variable: Leptin (ng.ml-1) 
 
 
 
4. Discussion 
 
In the present cross-sectional study, we analyzed interactions between plasma 
adiponectin and leptin levels with fat and lean indices, and with lipid profiles in 
34 older adults. We demonstrated a positive association between adiponectin 
with HDL-C. It is know that HDL-C and adiponectin play an important role in 
protecting against atherosclerosis, by removing cholesterol from atheroma and 
transporting it back to the liver. In human cell-line models (16), it was suggested 
that adiponectin might protect against atherosclerosis by increasing HDL-C. 
Park et al (2004) demonstrated that decreased adiponectin and increased 
leptin levels are significantly associated with metabolic risk factors for 
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 cardiovascular disease (12). Our results in older adults are in accordance to the 
outcomes from other groups who have also demonstrated that plasma HDL–C 
levels are positively correlated with plasma adiponectin concentrations in adults 
(9), patients with metabolic syndrome (17), end-stage renal disease (10) and 
older women with moderate weight loss (13). It has also been demonstrated 
that adiponectin levels correlate negatively with LDL-C in postmenopausal 
women (11); however, our results could not confirm this finding. This might be 
attributed to the low number of individuals, and the inclusion of both genders in 
our population. Our study also failed to control for alcohol intake that might 
increase adiponectin levels (18). 
Leptin was shown to have a trend towards a positively correlation with 
triglycerides, in accordance with results from previous studies (11, 13). In our 
study, leptin did not demonstrate a significant association with cholesterol 
levels. Despite the fact that Rolland et al (11) reported that leptin correlated 
positively with total cholesterol and LDL-C, and negatively with HDL-C, these 
results are not definitive, and further research in this area is still necessary (19).  
Android fat mass is a well-known predictive factor of the amount of visceral fat, 
therefore establishing an association between obesity and atherosclerotic 
vascular disease (20). Adiponectin and leptin concentrations are strongly 
influenced by visceral adipose tissue and by subcutaneous adipose tissue, 
respectively (12). Our study demonstrated that adiponectin is negatively 
associated with android fat mass. Other studies also reported that plasma 
adiponectin levels are negatively correlated with visceral fat mass (17, 21), fat 
mass (11), but positively correlated with plasma HDL-C (17). Furthermore, 
Kumada et al. (22) showed that male patients with hypoadiponectinemia had 
an increase in coronary artery disease prevalence, independent of well-known 
cardiovascular risk factors. Our study has shown an unexpected result, with a 
positive association between adiponectin and BMI levels, contrary to previous 
data that have demonstrated a negative correlation with BMI (9). This might be 
attributed to an increased lean mass in detriment of fat mass demonstrated by 
dual-energy x-ray absorptiometry (DEXA) results in these older subjects.  
Although clinical studies show strong relationships between adiponectin and 
leptin levels and body composition indices (7, 9, 12, 14), in general these 
studies are limited to anthropometric measurements  (BMI and/or waist-to-hip 
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 ratio [WHR]) or body fat mass, without using precise methods for detailed 
analysis of each component, as DEXA used in the present study. In clinical 
practice, the most frequent indicators of obesity are BMI and the WHR, which 
are measured to indicate the nutritional status and used to correlate the risk of 
health problems with weight at the population level in adults. Nevertheless, 
these indicators, although very common and relatively easy to obtain, do not 
allow a precise and unambiguous definition of the relations between individual 
body components and adipokines. Then, the obtained results highlight the high 
risk of error in the assessment of the relation between adiponectin and leptin 
levels and the nutritional status and body fat when only BMI is considered and 
indicate the need to analyze both fat and lean components.  
For leptin, there are no robust data in the literature. It has been shown to be 
positively correlated with both fat mass and lean mass (11). Our study 
demonstrated that leptin concentration was positively correlated with body 
mass, and negatively correlated with lean mass. These data corroborate the 
literature describing that plasma levels of leptin correlate positively with body 
adiposity, and leptin secretion is many times higher in obese compared with 
lean subjects (23).  
This study has several limitations. First, there was a limited number of subjects. 
However, our results provide background information on these poorly 
understood adipokines in untrained older subjects. Understanding the 
mechanisms associated with leptin and adiponectin level is relevant in the older 
population because this transition period is associated with an accelerated 
change in body composition and increased risk of cardiovascular disease (24, 
25). Second, because of the cross-sectional nature of the study, the causal 
nature of associations between adiponectin or leptin and the different variables 
could not be addressed. Despite these shortcomings, our study is one the few 
to report the relationship of leptin and adiponectin with lipid profile, body 
composition indexes evaluated by gold-standard methods among older adults. 
 
In summary, this cross-sectional study in untrained older subjects suggests that 
leptin is influenced by body mass and lean mass, and adiponectin is influenced 
by abdominal fat mass and HDL-C. Taking into account our data and the 
existing state of knowledge, the potential significance of leptin and adiponectin 
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 levels, as a central complementary diagnostic in the estimation and prevention 
of cardiovascular disease, needs further research. 
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Table 1 – Demographic and clinical baseline features 
 Group (n=34) 
 
Age (years) 
 
71.6 ± 7.3 
Female 26 (76.4) 
Obesity 6 (17.6) 
Diabetes 7 (20.5) 
Hypertension 15 (44.1) 
Ischemic Heart Disease 3 (8.8) 
Dyslipidemia 14 (41.1) 
Smoking  2 (5.8) 
Previous history of cancer 2 (5.8) 
Osteoporosis 13 (38.2) 
Thyroid disease 4 (11.7) 
Osteoarthritis 20 (58.8) 
Notes: Data for age are expressed as mean ± SD, and as  
n (%) for other variables. 
 
 
 
 
Table 2. Anthropometric, body composition and biochemistry characteristics  
at baseline 
  Mean SD N 
     
Body Mass (kg) 66.92 10.2 34 
Body Mass Index (kg.m-2) 27.60 3.5 34 
Percentage of Body Fat (%) 38.45 6.4 34 
Fat Mass (kg) 25.32 6.5 34 
Lean Mass (kg) 38.25 6.5 34 
Android Fat Mass (kg) 2.17 0.8 34 
Gynoid Fat Mass (kg) 3.75 0.9 34 
Percentage of Trunk Fat (%) 38.54 6.8 34 
Trunk Fat Mass (kg) 12.86 3.8 34 
Percentage of Android Fat (%) 40.23 7.8 34 
Percentage of Gynoid Fat (%) 38.25 5.9 34 
Leptin (ng.ml-1)* 4.32 1.9 34 
Adiponectin (ug.ml-1)* 3.38 0.8 34 
Triglycerides (mg.dL-1) 109.26 41.8 34 
Glucose (mg.dL-1)* 9.62 1.2 34 
Total Cholesterol (mg.dL-1) 206.76 35.5 34 
HDL Cholesterol (mg.dL-1) 53.70 9.9 34 
LDL Cholesterol (mg.dL-1) 131.30 30.6 34 
(*): Variables transformed for analysis (not normally distributed). 
 
 
 
 
 
 
 
 
 
 
 
Table Click here to download Table Tables.docx 
Table 3. Pearson correlation coefficients (r) between leptin or adiponectin,  
anthropometric body composition measures and biochemistry markers 
 Leptin  Adiponectin 
r P  r P 
Anthropometric and Body 
Composition Measures 
     
Body Mass (kg) .433   .005**  −.266 .064 
Body Mass Index (kg.m-2) .666 <.001**  −.076 .334 
Percentage of Body Fat (%) .847 <.001**  −.170 .169 
Fat Mass (kg) .806 <.001**  −.233 .092 
Lean Mass (kg) −.169 .170  −.153 .195 
Android Fat Mass (kg) .675 <.001**  −.335   .026* 
Gynoid Fat Mass (kg) .753 <.001**  −.164 .177 
Percentage of Trunk Fat (%) .846 <.001**  −.258 .070 
Trunk Fat Mass (kg) .768 <.001**  −.280 .054 
Percentage of Android Fat (%) .812 <.001**  −.321   .032* 
Percentage of Gynoid Fat (%) .766 <.001**  −.037 .417 
 
Biochemistry Characteristics 
 
     
Triglycerides (mg.dL-1) .311  .037*  −.189  .142 
Glucose (mg.dL-1) .303  .041*    .074  .339 
Total Cholesterol (mg.dL-1) .085 .316  −.110  .269 
HDL Cholesterol (mg.dL-1) −.029 .435    .346   .023* 
LDL Cholesterol (mg.dL-1) .025 .443  −.189  .142 
* P<0.05; ** P<0.01 
 
 
 
Table 4 - Relationship between dependent and independent variables 
  β P Value Collinearity 
VIF 
Adiponectin    
HDL Cholesterol (mg.dL-1)    0.346 0.045* 1,000 
Body Mass Index (kg.m-2)    0.605 0.035* 3,046 
Android Fat Mass (kg)  −0.831 0.005** 3,046 
Leptin    
Triglycerides (mg.dL-1)    0.311 0.073 1,000 
Body Mass (kg)    1.383 0.001** 2,458 
Lean Mass (kg)  −1.234 0.001** 2,458 
Dependent variables: Adiponectin and Leptin; Independent variables: HDL Cholesterol,  
Body Mass Index, Android Fat Mass, Triglycerides, Body Mass, and Lean Mass. 
 
 
 
 
 
 
 
Table 5. Results from stepwise multivariate linear regression analyses with serum Adiponectine 
and Leptinf as dependent variables and potential predictors as independent variables. 
 Change Statistics  
Mode
l 
R R 
Squar
e 
Adjuste
d R  
Square 
Std. 
Error of 
Estimat
e 
R 
Square 
Change
d 
F 
Chang
e 
D
f 
1 
D
f 
2 
Sig
. F 
Durbin-
Watso
n 
1e .346
a 
.120 .092 .76339 .120 4.347 1 32 .045 1.754 
2e .482
b 
.233 .183 .72416 .233 4.696 2 31 .017 2.261 
3f .898
c 
.807 .795 .86424 .807 64.872 2 31 .000 2.022 
4f .311
d 
.097 .069 1.84075 .097 3.434 1 32 .073 2.627 
a. Predictors: (Constant), HDL Cholesterol (mg.dL-1) 
b. Predictors: (Constant), Android Fat Mass (kg), Body Mass Index (kg.m-2) 
c. Predictors: (Constant), Lean Mass (kg), Body Mass (kg) 
d. Predictors: (Constant), Triglycerides (mg.dL-1) 
e. Dependent Variable: Adiponectin (ug.ml-1) 
 f.     Dependent Variable: Leptin (ng.ml-1) 
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Abstract 
Background: regular physical training has been shown to prevent sarcopenia, age-
related diseases, and to improve physical and functional performance. This study 
aimed to evaluate the effects of a concurrent combined endurance (ET) and 
resistance (RT) training in body composition, muscle strength, muscular endurance 
and cardiorespiratory fitness in older adults. Methods: fifty participants were 
assigned into experimental (EG) and control group (CG). Body composition, 
cardiorespiratory fitness, flexibility, muscular endurance, and lower limbs isokinetic 
strength were assessed at baseline and after 8 months. Training consisted of 30-min 
walking followed by 45-min RT, 3 times a week. General linear model was employed 
testing for group x time interactions. Results: significant (P<0.05) group x time 
interactions were found for isokinetic strength, with improvement in the EG for: 
right-knee flexion at 180°.s
-1
 (8.2 ± 2.2 Nm [P=0.017]), left-knee flexion at 60°.s
-1
 (4.8 
± 2.7 Nm [P=0.026]), and right-knee flexion at 60°.s
-1
 (6.0 ± 1.8 Nm [P=0.001]). Group 
x time interaction was also significant for muscular endurance with improvements 
for EG (5.6 ± 0.8 stands [P=0.015]), as well as flexibility (2.8 ± 1.9 cm [P=0.001]). 
Conclusion: concurrent 8-month AT and RT improves muscular endurance, lower-
limb flexibility and isokinetic strength, but not cardiorespiratory fitness in older 
adults.  
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INTRODUCTION 
 
Aging is accompanied by a reduction in lean body mass and an increase in fat mass, 
especially in the visceral depot, as well as worsening insulin resistance and glucose 
tolerance, dyslipidemia, and hypertension (24). The increase of older population and 
greater prevalence of frailty have led to growing concerns among healthcare 
professionals, seeking strategies to diminish and counteract age-related changes on 
muscle strength and cardiovascular endurance of older adults (12). In fact, declines 
in maximal aerobic capacity and sarcopenia are examples of functional declines with 
aging, which can severely limit physical performance and independence, which 
associate to mortality (21, 26, 27). 
 
Regular physical training has been shown to prevent age-related losses in muscle 
mass, physical function and several diseases (1). Therefore, international physical 
activity guidelines for older adults include both endurance (ET) and resistance 
training (RT) as means to improve overall health, reduce frailty and increase physical 
function (1). Indeed, evidence point that ET mainly improves aerobic capacity and 
reduces body fat, while RT primarily results in increases in muscle strength and mass. 
Several studies have been performed to find out the possible synergistic effects of 
combining endurance and strength training in older adults (3, 9, 32). Furthermore, 
combined ET and RT may lead to gains in muscular strength (16, 17) and 
cardiovascular fitness (4, 34), as well as improved load-carrying walk performance 
(15), when compared with either modality alone in older adults.  
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These findings suggest that a training program consisting of a combination of 
endurance and strength training may be an effective way to improve overall health 
and fitness in older adults. The inclusion of resistance training (to gain strength, 
hypertrophy, and power) combined with aerobic exercise (to enhance endurance) in 
the same sessions of a single exercise program is known as concurrent training (33). 
Thus, this study aimed to evaluate the effects of a concurrent ET and RT program on 
body composition, muscle strength and cardiorespiratory fitness in older adults. 
 
METHODS 
Experimental Approach to the Problem 
The hypothesis of this study is that endurance combined with resistance training 
may significantly improve the functional capacity of older adults. 
 
Subjects 
Untrained adults aged 60 years or older were invited to participate in this study. 
Volunteers were recruited from two sources: individuals from the local community 
that were on a waiting list for physical activity, and through advertisements. 
Participants completed a health history questionnaire to record past and present 
conditions. By convenience, experimental (EG) and control groups (CG) were 
assigned. Participants were evaluated at baseline and after 8 months of exercise. 
Two individuals in each group did not complete baseline assessments. Thirty-four of 
remaining 46 subjects completed the experimental protocol, 18 in the EG and 16 in 
the CG. In EG assiduity at exercise sessions was 94.08 ± 3.07%. 
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In baseline demographic and clinical features (Table 1), CG and EG differed only with 
regard to age (P<0.05). 
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Table 1 – Demographic and clinical baseline features 
 Control Group (n=16) Experimental Group(n=18) 
Age (years) 75.1 ± 6.5 68.5 ± 6.7 * 
Female 11 (68.8) 15 (83.3) 
Obesity 2 (12.5) 4 (22.2) 
Diabetes 3 (18.8) 4 (22.2) 
Hypertension 7 (43.8) 8 (44.4) 
Ischemic Heart Disease 3 (18.8) 0 (0) 
Dyslipidemia 4 (25) 10 (55.6) 
Smoking  0 (0) 2 (11.1) 
Previous history of cancer 0 (0) 2 (11.1) 
Osteoporosis 8 (50) 5 (27.8) 
Thyroid disease 1 (6.3) 3 (16.7) 
Osteoarthritis 10 (62.5) 10 (55.6) 
Notes: Data for age are expressed as mean ± SD, and as n (%) for other variables; * 
P<0.05 for group differences. 
 
The study was approved by the Ethics Committee and the Scientific Board from the 
Faculty of Sport, University of Porto. All subjects were informed of the benefits and 
risks of the investigation prior to signing an institutionally approved informed 
consent document to participate in the study. 
 
Procedures 
Assessment of Body Composition 
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Body weight was measured with an electronic weight scale (SECA 708). Subjects 
were weighed barefoot wearing light clothing. Height was measured to the nearest 1 
mm with a standard stadiometer. Body composition was determined using a Dual-
energy X-ray Absorptiometry (DXA, Hologic QDR-4500, software for Windows XP, 
version 12.4) in the supine position. The same investigator analyzed all body scans. 
The principles behind body composition analyses with DXA are explained elsewhere 
(18). 
 
Assessment of Isokinetic Strength 
Dynamic concentric muscle strength was measured through an isokinetic 
dynamometer (BIODEX System 4 Pro; Biodex, Shirley, NY). The main outcome for 
isokinetic strength was peak torque (Nm), assessed in accordance with 
manufacturer's instructions for knee flexion and extension, at two angular velocities: 
60°.s
-1
 (1.05 rad .s
-1
) and 180°.s
-1
 (3.14 rad .s
-1
). Each participant, after familiarization 
with the machine, performed five maximal efforts at 180°.s
-1
 and three at 60°.s
-1
 
with 2 minutes of rest between tests. The dynamometer angle reading was 
calibrated to the anatomic joint angle measured by a goniometer, and gravity 
corrections to torque were based on leg weight at 0° and calculated by the 
equipment software. Prior to testing, subjects performed a 5-minute warm-up on a 
bicycle ergometer (Bike-Max; Tectrix, Irvine, CA) at 45–60 W. During the test, 
participants were verbally encouraged to exert maximal force. Peak torque (Nm), 
represented as a percentage normalized to body weight, was used for the statistical 
analyses. 
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Physical and Functional Fitness Assessment 
The Functional Fitness Test Battery consists of 6 items, designed and validated to 
assess the functional parameters that support physical mobility in older adults (25). 
Lower body strength was measured using the 30-second chair-stand test. Upper 
body strength was assessed using the arm-curl test. Lower-body flexibility was 
assessed using the chair sit-and-reach test. Agility/dynamic balance was assessed 
using the 8-foot up-and-go test. Aerobic endurance was measured using the 6-min 
walk test that was administrated on a different day. After a demonstration by the 
tester, a practice trial of 2 repetitions, followed by 1 test trial was performed. The 
best score of 2 trials was used to evaluate performance in the chair sit-and-reach, 
back scratch and 8-foot up-and-go tests. Full detailed information on test 
administration and protocols can be found in Rikli and Jones (25). 
 
Training Protocol 
The EG completed 8 months of a concurrent exercise training program, consisting of 
three sessions per week, with at least one day of rest bet een sessions. Each session 
lasted 90 minutes and was conducted by two physical education instructors and 
included: (1) a period of a standardized warm-up (5-8 minutes); (2) 30 minutes of ET: 
walking corresponding to 65-85% HRmax and the target heart rate during exercise 
continuously monitored by HR monitors (Polar Vantage XL, Polar Electro Inc., Port 
Washington, NY); 15 minutes of rest, followed by (3) 45 minutes of RT; and (4) a 
cool-down period (5-8 minutes) that included slow walking and stretching exercises.  
 The RT protocol aimed to develop muscle mass and strength on variable-resistance 
machines (Nautilus Sports/Medical Industries, Independence, USA), in the following 
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muscle groups: (1) quadriceps (leg press and leg extension), (2) hamstrings (seated 
leg curl), (3) gluteal (hip abduction), (4) trunk and arms (double chest press, lateral 
raise and overhead press), and (5) abdominal wall (abdominal machine). To minimize 
fatigue, the exercises for the upper/lower parts of the body were performed in a 
non-consecutive way, with a rest period of approximately 2 minutes between each 
set. Each repetition lasted 3 to 6 seconds, involving a period of 10–12 repetitions at 
60–80% of one repetition maximum tests (1RM). 
 
RT intensity was gradually increased during the first 4 weeks. Participants underwent 
a 2-week adaptation period with the equipment and the exercises. The intensity of 
the training stimulus was initially set at 50% to 60% of 1RM, as determined at week 
2, with a work range of two sets of 10 to 15 repetitions. Subjects then progressed 
from 60% to 80% of 1RM at a work range of 6 to 8 repetitions (2 sets) and remained 
at this level until the end of the training program. One repetition maximum tests 
were performed every 2 weeks for the first month and then every 4 weeks until the 
end of the program. Between these tests, the load was increased for those subjects 
who were able to easily complete 12 or more repetitions for both sets. 
Both exercise-training programs were planned for intensities recommended by the 
ACSM (11). The CG was proposed to maintain the same daily habits and performed 
the same evaluation as EG at baseline and at 8 months by the same investigator. 
After the experimental protocol, CG was invited to participate in exercise sessions. 
 
Statistical Analyses 
At baseline, between-group comparisons were performed using Student's 
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independent t-test and the Chi-square test, as appropriate. The effectiveness of the 
concurrent ET and RT program was analyzed through General Linear Model 
(Repeated-Measures ANOVA with Bonferroni corrections) testing for group x time 
interactions. When a significant group x time interaction was observed, a Univariate 
General Linear Model was performed to ascertain the differences at the final 
assessment between CG and EG. All General Linear Models analyses were carried 
out with age as a covariate. Partial eta-squared (η
2
p) was reported as the effect-size 
measure. All analyses were carried out in SPSS version 21.0 for Mac OSX (SPSS Inc., 
Chicago, IL, USA), with a two-sided statistical significance set at 5%.  
 
RESULTS 
Anthropometric and fitness characteristics at baseline are described in Table 2. 
Differences between groups were found for Peak Torque - Extension - Left – 180
o
.s
-1
 
(P<0.05), Peak Torque - Extension - Right - 60
 o
.s
-1
 (P<0.05), 8-Ft Up & Go, Chair Stand 
(P<0.001), Arm Curl (P<0.05) and 6-Min Walk (P<0.001). Considering baseline 
differences, further analyses were adjusted for age. 
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Table 2 – Anthropometric and fitness characteristics at baseline  
 Control Experimental 
Height (cm) 154.1 ± 7.7 157.0 ± 8.1 
Body Mass (kg) 64.9 ± 10.9 68.8 ± 9.4 
Body Mass Index (kg.m
-2
) 27.2 ± 3.5 27.9 ± 3.7 
Percentage of Body Fat (%) 37.4 ± 6.8 39.4 ± 6.1 
Fat Mass (kg) 23.8 ± 6.4 26.7 ± 6.5 
Lean Mass (kg) 37.7 ± 7.2 38.8 ± 6.0 
Peak Torque - Extension - Left – 180
o
.s
-1
 (N m) 30.4 ± 8.2 37.6 ± 10.0* 
Peak Torque - Extension - Right - 180
 o
.s
-1
 (N m) 27.5 ± 9.7 37.1 ± 21.1 
Peak Torque - Flexion - Left - 180
 o
.s
-1
 (N m) 21.5 ± 6.4 23.7 ± 11.7 
Peak Torque - Flexion - Right - 180
 o
.s
-1
 (N m) 14.9 ± 5.5 19.3 ± 14.0 
Peak Torque - Extension - Left - 60
 o
.s
-1
 (N m) 67.9 ± 18.0 83.1 ± 31.9 
Peak Torque - Extension - Right - 60
 o
.s
-1
 (N m) 60.2 ± 25.4 84.4 ± 32.9* 
Peak Torque - Flexion - Left - 60
 o
.s
-1
 (N m) 33.6 ± 12.5 41.8 ± 18.0 
Peak Torque - Flexion - Right - 60
 o
.s
-1
 (N m) 31.3 ± 14.4 38.6 ± 17.3 
8-Ft Up & Go (s) 6.3 ± 1.4 4.8 ± 0.5* 
Chair Stand (no. of stands) 13.3 ± 2.1 18.3 ± 3.4** 
Arm Curl (no. of reps) 16.4 ± 2.6 20.9 ± 4.2* 
6-Min Walk (m) 452.8 ± 62.9 570.3 ± 78.2** 
Chair Sit & Reach (cm) -6.4 ± 10.8 -1.7 ± 9.8 
Back Scratch (cm) -11.0 ± 8.3 -8.9 ± 8.3 
Notes: Data are expressed as mean ± SD; * P<0.05 for group differences; ** P<0001 for 
group differences 
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Table 3 shows the changes in anthropometrics, isokinetic muscle strength and 
physical fitness for both groups. No significant group x time interaction was found in 
the anthropometric measurements. There was also no significant group x time 
interactions in some functional tests: 8-FT Up & Go, Arm Curl, 6-min walk and back 
scratch. On the other hand, significant main effects for group x time interactions (P 
<0.05) were found for lower limbs isokinetic strength, lower body muscular 
endurance and flexibility, indicating that the 8-month concurrent ET and RT program 
was effective to promote changes in these parameters.
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Table 3 – Adjusted anthropometric and fitness values and effects for the concurrent endurance and resistance training intervention  1 
 Control Experimental Effect 1 Effect 2 Mean Difference 
 Baseline Final Baseline Final η2p η2p 95 % CI (LB to UB) 
Body Mass (kg) 65.8 (2.7) 65.6 (2.9) 67.9 (2.5) 68.5 (2.7) 0.017   
Body Mass Index (kg.m
-2
) 27.7 (0.9) 27.6 (1.0) 27.5 (0.9) 27.7 (0.9) 0.013   
Percentage of Body Fat (%) 38.7 (1.6) 38.7 (1.7) 38.3 (1.5) 37.4 (1.6) 0.033   
Fat Mass (kg) 25.1 (1.6) 25.2 (1.6) 25.6 (1.5) 24.9 (1.5) 0.016   
Lean Mass (kg) 37.4 (1.8) 37.5 (1.9) 39.0 (1.7) 39.7 (1.7) 0.031   
Peak Torque - Extension - Left – 180
o
.s
-1
 (N m) 30.2 (2.5) 30.7 (2.8) 37.8 (2.3) 45.9 (2.6) 0.089   
Peak Torque - Extension - Right - 180
 o
.s
-1
 (N m) 27.4 (4.5) 33.4 (3.9) 37.1 (4.3) 50.8 (3.7) 0.044   
Peak Torque - Flexion - Left - 180
 o
.s
-1
 (N m) 20.6 (2.6) 15.7 (2.1) 24.5 (2.4) 24.6 (2.0) 0.062   
Peak Torque - Flexion - Right - 180
 o
.s
-1
 (N m) 15.3 (2.9) 15.0 (3.0) 18.9 (2.7) 27.2 (2.8) 0.171* 0.202* 12.136 (3.294 to 20.977) 
Peak Torque - Extension - Left - 60
 o
.s
-1
 (N m) 66.5 (7.1) 66.0 (6.9) 84.3 (6.6) 91.0 (6.5) 0.024   
Peak Torque - Extension - Right - 60
 o
.s
-1
 (N m) 60.3 (8.0) 73.8 (6.8) 84.2 (7.5) 100.2 (6.4) 0.004   
Peak Torque - Flexion - Left - 60
 o
.s
-1
 (N m) 34.1 (4.2) 29.0 (4.3) 41.4 (4.0) 46.2 (4.0) 0.151* 0.201* 17.166 (4.611 to 29.721) 
Peak Torque - Flexion - Right - 60
 o
.s
-1
 (N m) 31.5 (4.3) 27.4 (3.8) 38.4 (4.1) 44.5 (3.6) 0.305* 0.233* 17.051 (5.714 to 28.388) 
8-Ft Up & Go (s) 6.1 (0.3) 5.9 (0.2) 5.0 (0.2) 4.6 (0.2) 0.064   
Chair Stand (no. of stands) 13.6 (0.8) 15.8 (1.3) 18.0 (0.7) 23.7 (1.2) 0.177* 0.359** 7.905 (4.035 to 11.775) 
Arm Curl (no. of reps) 17.0 (0.9) 19.2 (1.1) 20.4 (0.8) 24.4 (1.0) 0.057   
6-Min Walk (m) 473.0 (16.4) 485.1 (16.2) 552.3 (15.3) 583.6 (15.2) 0.028   
Chair Sit & Reach (cm) -5.6 (2.8) -8.8 (2.8) -2.4 (2.6) 0.4 (2.7) 0.292* 0.139* 9.201 (.806 to 17.596) 
Back Scratch (cm) -9.8 (2.2) -7.3 (1.9) -9.9 (2.0) -8.4 (1.8) 0.007   
Notes: Data are expressed as mean (SE); * P<0.05 for group differences; ** P<0001 for group differences; Effect 
1
: Partial Eta Square (η
2
p)for group x time interactions; Effect 
2
: Partial Eta Square (η
2
p) for differences 2 
in the final evaluation; Mean Difference: differences between groups (EG – CG) at the final evaluations with values described as mean difference and respective 95% Confidence Interval (Lower to Upper Bound). 3 
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As shown in Table 3, significant group x time interactions were observed in the peak torque 
of the right leg flexion at 180
o
.s
-1
 (P=0.017; η
2
p=0.171). This finding was confirmed by a 
significant mean difference between groups in the peak torque of the right leg flexion at 
180
o
.s
-1
 observed at the final assessment (P=0.009; η
2
p=0.202). Thus, peak torque of the 
right leg flexion at 180
o
.s
-1
 improved significantly in the EG [27.2 (2.8) N m] compared with 
the CG [15.0 (3.0) N m]. Likewise, a significant group x time interaction was observed in the 
peak torque of the left leg flexion at 60
o
.s
-1
 (P=0.026; η
2
p=0.151), a finding that was 
confirmed by the mean difference between groups in the peak torque of the left leg flexion 
at 60
o
.s
-1
 at the final assessment (P=0.009; η
2
p=0.201). Thus, peak torque of the left leg 
flexion at 60
 o
.s
-1
 also improved significantly in the EG [46.2 (4.0) N m] compared with the CG 
[29.0 (4.3) N m]. Moreover, a significant group x time interaction was observed in the peak 
torque of the right leg flexion at 60
o
.s
-1
 (P=0.001; η
2
p=0.305). This was also confirmed by the 
mean difference between groups in the peak torque of the right leg flexion at 60
o
.s
-1
 at the 
final assessment (P=0.004; η
2
p=0.233). Thus, peak torque of the right leg flexion at 60
o
.s
-1
 
also improved significantly in the EG [44.5 (3.6) N m] compared to the CG [27.4 (3.8) N m]. 
A significant group x time interaction was observed in the test of lower body muscular 
endurance (chair stand) (P=0.015; η
2
p=0.177), which was confirmed by the mean difference 
between groups in the chair stand at the final assessment (P<0.001; η
2
p=0.359). Accordingly, 
chair stand improved significantly in the EG [23.7 (1.2) n° of stands] compared with the CG 
[15.8 (1.3) n° of stands]. 
 
Finally, a significant group x time interaction was observed in the test of flexibility of the 
lower limbs (chair sit & reach) (P=0.001; η
2
p=0.292). This finding was confirmed by the 
significant mean difference between groups in the chair sit & reach observed at the final 
Page 13 of 22
Human Kinetics, 1607 N Market St, Champaign, IL 61825
Journal of Physical Activity and Health
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
For Peer Review
Running head: EXERCISE IMPROVES FUNCTIONAL CAPACITY 
 
 
14 
 
assessment (P=0.033; η
2
p=0.139). Therefore, chair sit & reach also improved significantly in 
the EG [0.40 (2.7) cm] compared with the CG [-8.80 (2.8) cm]. 
 
DISCUSSION 
Eight-month concurrent ET and RT increased lower-limb strength for knee flexors, muscular 
endurance and flexibility in older adults. However, despite aerobic exercises were in 
accordance with the ACSM recommended guidelines (1, 23), the protocol was not effective 
to improve peak torque of knee extension and cardiorespiratory fitness. 
 
Aging is associated with a gradual decrease in strength and muscular endurance (28), with a 
more rapid decrease after the age of 60 years (29). It has already been demonstrated that 
the loss of strength in the lower body is faster than in the upper body (13). With decreased 
body strength, the walking speed and stair climbing ability decrease, and the frequency of 
falls increases(22). Regular physical activity is an important therapeutic tool for preventing 
muscle strength loss (7, 8). Our results with long-term combined endurance and resistance 
training demonstrated a significant increase of lower-limb strength, especially for peak 
torque of knee flexors at 60º.s
-1
 and 180º.s
-1
. Lee et al (20) also demonstrated that the 
absolute peak torque in combined endurance and resistance training increased significantly 
more than it did in the endurance training group. There was a significant increase in the 
60º.s
-1
 flexion and extension after 8 weeks of training 5 times per week. Two studies with 
shorter period of combined training demonstrated a significant improvement of knee 
extension (9, 14). 
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Ferrari et al (2013) (10) did not demonstrate that longer (20 week) concurrent training had a 
significant impact in peak torque knee extension at 60º.s
-1
. In accordance with this previous 
study, no significant improvement in knee extension at 60º.s
-1
 and 180º.s
-1
 was described in 
our results. 
 
Two functional ability tests (arm curl and chair stand) that have been validated as measures 
of muscle strength (25) were conducted in the present study to establish the effects of 
combined training. Our results are similar to those of previous studies that found improved 
chair stand performance (5, 6, 19, 31, 32) with combined training in older adults.  Contrary 
to other two previous studies (5, 31) we did not shown a significant improvement in arm-curl 
performance. 
 
The flexibility loss with aging is associated with muscle disuse and soft tissue restraints, with 
a consequent deterioration of functional abilities in this population (1). This study 
demonstrated a significant improvement in lower flexibility measured by sit and reach test, 
in accordance with other similar designed study in older adults (5). However, contrary to 
Carvalho et al (2009) (5)there was not a significant improvement in the upper flexibility, 
measured by back scratch test. It is interesting to note that in the present study there was 
no specific training for the improvement of flexibility. 
 
Cardiorespiratory endurance is defined as the ability to perform dynamic, moderate-to-high 
intensity work using a large muscle mass for an extended period of time (2). Toreman et al 
(31) demonstrated that improved cardiorespiratory fitness seems to be  an important 
therapeutic tool for preventing age-related muscle strength and endurance loss. Most 
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studies demonstrated that combined resistance and endurance training improves 
cardiorespiratory fitness measured by 6-min walk test (14, 31) or VO2 max (3, 4, 6, 9, 30, 32) in 
older adults. Although there was a 31-meter increase in the distance walked in the EG of the 
current study, this difference was not statistical significant from baseline. Carvalho et al (5) 
published similar results in elderly women, with twice a week and 60 min session combined 
training. This lack of improvement in both studies might be explained by the lower 
frequency and duration of aerobic exercise sessions. According to Gudlaugsson et al (14), 30 
min of ET daily with twice-weekly RT seems to be necessary to improve 6MWT performance.  
 
The strengths of this study are the intensity and the 8-month duration, a control group and a 
carefully defined and supervised activity by at least 2 health professional guiders. 
Furthermore the assessments by DXA (body composition) and isokinetic dynamometer 
(body strength) were performed at baseline and at the end of the training period. The study 
limitations included the small sample size and the non-randomized design. The statistical 
procedures were carried out in order to adjust to group differences at baseline, assuming 
group x time interactions main effects as major indicators of the actual effect of the 
combined exercise training protocol over the dependent variables.   Additionally, the effects 
of environmental and behavioral factors are difficult to control during such a long training 
period. 
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Abstract 
 
The aging process alters the secretion, synthesis, and function of the 
adipokines. Only a few studies have evaluated the impact of combined 
resistance and aerobic training on the adipokine levels of older adults. The 
aim of this study was to investigate the effects of concurrent aerobic and 
resistance training on the plasma levels of PAI-1, TNF-α, resistin, adiponectin, 
and leptin, as well as the lipid profile in older adults. Thirty-four individuals 
(n=18 exercise group [EG]; n= 16 control group) were included. The EG 
completed 8 months of a concurrent aerobic and resistance training program.  
The proposed training did not result in significant changes in adiponectin, 
leptin, resistin, and TNF-alpha or PAI-1 concentrations. There was a non-
significant decrease in total cholesterol and triglyceride levels after training. 
These results suggest that concurrent training do not significantly impact lipid 
and adipokines levels. 
 
Keywords: adipokines, lipid profile, older adults, concurrent training 
 
  
 1 
 2 
 3 
 4 
 5 
 6 
 7 
 8 
 9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
25 
26 
27 
28 
29 
30 
31 
32 
33 
34 
35 
36 
37 
38 
39 
40 
41 
42 
43 
44 
45 
46 
47 
48 
49 
50 
51 
52 
53 
54 
55 
56 
57 
58 
59 
60 
61 
62 
63 
64 
65 
1. Introduction   
 
Aging is a complex process that leads to changes in body composition and 
profound effects on the health and physical function. There is gradual 
accumulation of body fat and its redistribution to central and visceral depots, 
with an increased risk of metabolic (Janssen and Ross 2005; Racette and 
others 2006) and cardiovascular disease (CVD) (Kay and Fiatarone Singh 
2006; Singh 2004), the latter remaining a leading cause of morbidity and 
mortality among older adults (Jensen and others 2014). Furthermore, type 2 
diabetes (T2D) is also an important age-related chronic disease associated 
with reduction in skeletal muscle strength and mass and an increase in body 
fat and blood inflammatory markers (Donath and Shoelson 2011). 
The adipose tissue is an endocrine organ known to express and secrete a 
variety of bioactive peptides, known as adipokines, such as leptin, 
adiponectin, resistin, tumor necrosis factor alpha (TNF-α) and plasminogen 
activator inhibitor 1 (PAI-1), which regulate glucose homeostasis as well 
inflammatory responses (Kershaw and Flier 2004). The aging process alters 
the function, size, and number of adipose cells, which leads to alterations in 
the secretion, synthesis, and function of the adipokines (Gulcelik and others 
2013; Reilly and others 2005). 
 
Both physical activity and exercise training have been proposed as natural 
antioxidant and anti-inflammatory strategies to prevent the evolution and 
complications of CVD and T2D (American College of Sports and others 2009). 
These disorders and physical inactivity have been associated with chronic 
low-grade systemic inflammation reflected by elevated levels of several 
proinflammatory cytokines (Nicklas and Brinkley 2009; Petersen and 
Pedersen 2005). However, literature shows conflicting results about the 
positive benefits from exercise training, something that might be attributed to 
different training protocols (Kelley and Kelley 2006; Monzillo and others 
2003). 
Concurrent training (CT) is a model of exercise prescription that combines 
strength training and aerobic capacity in the same period of time and that has 
been extensively investigated in recent years (Beavers and others 2010; 
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Gondim and others 2015; Jorge and others 2011; Ligibel and others 2009; 
Markofski and others 2014). However, a limited number of studies have 
evaluated the impact of combined resistance and aerobic training in adipokine 
levels of older adults. Two longitudinal studies have demonstrated increased 
adiponectin levels with 12 and 16 weeks of combined resistance and aerobic 
training in healthy (Markofski and others 2014) and diabetic (Brooks and 
others 2007) older subjects. However, studies have not demonstrated a 
benefit of concurrent training in terms of leptin (Gondim and others 2015; 
Ligibel and others 2009), resistin (Gondim and others 2015; Jorge and others 
2011) or TNF-α levels (Beavers and others 2010; Gondim and others 2015; 
Jorge and others 2011). The heterogeneity of these studies, the small 
samples sizes and lack of control in dietary intake and habitual daily physical 
activity makes it difficult to draw firm conclusions regarding the impact of 
exercise on adipokine levels. The purpose of the present study was to 
investigate the effects of concurrent aerobic and resistance training on the 
plasma adipokine levels and the lipid profile in older adults.  
 
2. Material and methods 
 
2.1 Participants and Study Design 
 
This study was performed at the Faculty of Sports, University of Porto, 
Portugal. Fifty untrained adults aged 60 years or older were invited to 
participate through one of two sources: a waiting list for physical activity 
offered to individuals from the local community, and advertisements posted at 
various sites in the Porto area. During screening, participants were invited to 
complete a health history questionnaire to record past and present conditions 
(Table 1).   
Participants were non-randomly allocated to an experimental (EG) and a 
control group (CG). Participants were evaluated at baseline and after 8 
months of exercise program with regard to a series of parameters described 
below. Exclusion criteria included the following: aged <60 years; being active 
in the previous 12 months (engaging in moderate to vigorous physical 
activities at least 2 days a week for 20 min or more), any unstable medical 
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conditions or contraindication to exercise (e.g., unstable angina, frailty, severe 
renal or hepatic disease, uncontrolled epilepsy, progressive neurological 
disease, chronic disabling arthritis, and advanced osteoporosis). Two 
individuals in each group did not complete baseline assessments. Thirty-four 
subjects completed the experimental protocol, 18 in the EG and 16 in the CG. 
In the EG, assiduity at exercise sessions was 94% ± 3%. 
The nature, benefits, and risks of the study were explained to the volunteers, 
and their written informed consent was obtained before entry into the study. 
The study was carried out in accordance with the Declaration of Helsinki, with 
prior approval from the Ethics Committee and the Scientific Board from the 
Faculty of Sport, University of Porto, for all methods, protocols and 
procedures. 
  
2.2 Intervention 
 
2.2.1 Experimental Group 
 
The EG completed 8 months of a concurrent exercise training program, 
consisting of three sessions per week, with at least one day of rest between 
sessions.  
 
Each session lasted approximately 90 minutes (9:30 AM until 11:00 AM) and 
was conducted by a physical education instructor with specialization in older 
adults and included: (1) a period of a standardized warm-up (5-8 minutes); (2) 
30 minutes of endurance training (ET), namely walking corresponding to 65-
85% HRmax (220 - age) with the target heart rate (HR) during exercise being 
continuously monitored by HR monitors (Polar Vantage XL, Polar Electro Inc., 
Port Washington, NY); followed by (3) 45 minutes of resistance training (RT); 
and (4) a cool-down period (5-8 minutes) that included slow walking and 
stretching exercises.   
The RT protocol aimed to develop muscle mass and strength on variable-
resistance machines (Nautilus Sports/Medical Industries, Independence, 
USA), in the following muscle groups: (1) quadriceps (leg press and leg 
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extension), (2) hamstrings (seated leg curl), (3) gluteal (hip abduction), (4) 
trunk and arms (double chest press, lateral raise and overhead press), and (5) 
abdominal wall (abdominal machine). To minimize fatigue, the exercises for 
the upper/lower parts of the body were performed in a non-consecutive way, 
with a rest period of approximately 2 minutes between each set. Each 
repetition lasted 3 to 6 seconds, involving a period of 10–12 repetitions at 60–
80% of one repetition maximum tests (1RM). 
Resistance training intensity was gradually increased during the first 4 weeks. 
Participants underwent a 2-week adaptation period with the equipment and 
the exercises movements. The intensity of the training stimulus was initially 
set at 50% to 60% of 1RM, as determined at week 2, with a work range of two 
sets of 10 to 15 repetitions. Subjects then progressed from 60% to 80% of 
1RM at a work range of 6 to 8 repetitions (2 sets) and remained at this level 
until the end of the training program. One repetition maximum tests were 
performed every 2 weeks for the first month and then every 4 weeks until the 
end of the program. Between these tests, the load was increased for those 
subjects who were able to easily complete 15 or more repetitions for both 
sets. 
Both exercise-training programs were planned for intensities recommended 
by the American College of Sports Medicine (Garber and others 2011).  
 
2.2.2 Control Group 
 
The CG, not enrolled in the training program, was recommended to maintain 
their same daily habits and performed the same evaluation as the EG at 
baseline and at 8 months by the same investigator. After the 8-month 
observation period, they were invited to participate in specific exercise 
programs designed for seniors at the Faculty of Sport. 
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2.3 Measurements 
 
2.3.1 Anthropometrics 
 
Body weight was measured to the nearest 0.1 kg with an electronic weight 
scale (SECA 708). Subjects were weighed barefoot wearing light clothing. 
Height was measured to the nearest 1 mm with a standard stadiometer. Body 
composition (% of Body Fat, Fat Mass and Lean Mass) was determined using 
a Dual-energy X-ray Absorptiometry (DXA, Hologic QDR-4500, software for 
Windows XP, version 12.4) with subjects in the supine position. The same 
investigator analyzed all body scans. The principles behind body composition 
analyses with DXA are explained elsewhere (Kelly and others 1998). 
 
2.3.2 Blood Sampling and Biochemichal Analysis  
 
All blood samples were collected in the early morning (between 7 and 9 AM) 
after a 12-hour fast at baseline and the 8-month assessment.  
Blood samples were collected in Terumo Venosafe® Serum-Gel tubes. 
Serum was separated within 30 min from blood collection, after centrifugation 
for 10 min at 400x g. Aliquots of serum were stored at -80ºC until use. 
Total cholesterol, high-density lipoprotein (HDL) cholesterol, low-density 
lipoprotein (LDL) cholesterol, triglycerides and glucose were measured by a 
colorimetric assay, using the Olympus Diagnostics AU5400 analyser system 
(Beckman Coulter, USA).  
Adiponectin, PAI-1, leptin, TNF-α, and resistin were measured by a multiplex 
analysis assay (Millipore, Hamburg, Germany). Briefly, the appropriate 
cytokine standards, controls and plasma samples were diluted in assay buffer 
and added to pre-wet filter plates. Fluorescent beads containing adiponectin, 
PAI-1, leptin, TNF-α, and resistin antibodies were added and incubated on a 
plate shaker overnight, at 4ºC. The wells were washed, and the samples were 
incubated with detection antibodies, for 30 minutes at room temperature and 
with streptavidin-phycoerythrin, under the same conditions. After washing, 
beads were resuspended with sheath fluid and analyzed on a Luminex 200TM. 
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Mean fluorescent intensity data (MFI) were analyzed using the Luminex 100 
Integrated System version 2.3 (Luminex Corporation, USA).  
 
2.3.3 Dietary intake 
 
The dietary intake (expressed in Kcal) assessment was performed by a 3-day 
dietary record (two weekdays and one weekend day) at two time points 
(before and after the intervention). Participants were invited to record and 
weigh all foods and drinks consumed on each recording day, trying to not 
change their eating habits while keeping the record, and then to bring the 
completed records to the research team. Dietary records were analyzed using 
an adapted Portuguese version of the software Food Processor Plus® (ESHA 
Research Inc, Salem, Oregon, USA), a nutritional analysis software that 
converts food intake into total energy and nutrients, based on food 
composition tables available from the United States Department of Agriculture 
and national data from typical Portuguese foods.  
 
2.4 Statistical Analysis  
At baseline, between-group comparisons were performed using Student's 
independent t-test and the Chi-square test, as appropriate. Before analysis, 
logarithm or square root transformations of the data were performed to 
normalize skewed distributions. Nevertheless, the data are presented in the 
original scale for clarity (Table 2). The effectiveness of the concurrent aerobic 
and resistance-training program was analyzed through General Linear Model 
(Repeated-Measures ANOVA with Bonferroni corrections) testing for group 
versus time interactions. When a significant interaction was observed, a 
Univariate General Linear Model was performed to ascertain the differences 
at the final assessment between control and experimental groups. All General 
Linear Models analyses were carried out with age as a covariate. Partial eta-
squared (η2p) was reported as the effect-size measure. All analyses were 
carried out in SPSS version 21.0 for Mac OSX (SPSS Inc., Chicago, IL, USA), 
with a two-sided statistical significance set at 5%.  
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3. Results 
In terms of baseline demographic and clinical features (Table 1), the CG and 
EG differed only with regard to age (P<0.05). Moreover, comparisons 
between participants who dropped out and those who completed the study 
revealed no significant differences in their baseline values (data not shown). 
Regarding anthropometric and biochemistry characteristics at baseline (Table 
2), differences between groups were found for TNF-α (P<0.05). Considering 
baseline differences, further analyses were adjusted for age. 
 
Table 1 – Demographic and clinical baseline features 
 Control Group (n=16) Experimental Group (n=18) 
Age (years) 75.1 ± 6.5 68.5 ± 6.7 * 
Female 11 (68.8) 15 (83.3) 
Obesity 2 (12.5) 4 (22.2) 
Diabetes 3 (18.8) 4 (22.2) 
Hypertension 7 (43.8) 8 (44.4) 
Ischemic Heart Disease 3 (18.8) 0 (0) 
Dyslipidemia 4 (25) 10 (55.6) 
Smoking  0 (0) 2 (11.1) 
Previous history of cancer 0 (0) 2 (11.1) 
Osteoporosis 8 (50) 5 (27.8) 
Thyroid disease 1 (6.3) 3 (16.7) 
Osteoarthritis 10 (62.5) 10 (55.6) 
Notes: Data for age are expressed as mean ± SD, and as n (%) for other variables; * P<0.05 
for group differences. 
 
 
Table 2 – Anthropometric and biochemistry characteristics at baseline  
 Control Experimental 
Height (cm) 154.1 ± 7.7 157.0 ± 8.1 
Body Mass (kg) 64.9 ± 10.9 68.8 ± 9.4 
Body Mass Index (kg.m
-2
) 27.2 ± 3.5 27.9 ± 3.7 
Percentage of Body Fat (%) 37.4 ± 6.8 39.4 ± 6.1 
Fat Mass (kg) 23.8 ± 6.4 26.7 ± 6.5 
Lean Mass (kg) 37.7 ± 7.2 38.8 ± 6.0 
Leptin (ng.ml) 19.4 ± 19.3 24.7 ± 17.6 
Resistin (ng.ml) 6.2 ± 1.9 6.5 ± 1.9 
PAI-1 (ng.ml) 24.8 ± 17.1 23.5 ± 12.6 
Adiponectin (ug.ml) 13.6 ± 5.8 10.7 ± 5.3 
TNF-α (pg/mL) 6.2 ± 2.9 4.1 ± 1.7* 
Total Cholesterol (mg.dL)  198.9 ± 27.0 213.8 ± 41.17 
HDL Cholesterol (mg.dL) 52.1 ± 10.4 55.1 ± 9.5 
LDL Cholesterol (mg.dL) 126.1 ± 23.6 135.7 ± 35.9 
Triglycerides (mg.dL) 103.5 ± 34.5 114.4 ± 47.9 
Glucose (mg.dL) 89.9 ± 18.8 97.7 ± 30.1 
Total Physical Activity (Steps.day
-1
) 5574.7 ± 2610.8 6652.7 ± 2959.2 
Notes: Data are expressed as mean ± SD; * P<0.05 for group differences. These are 
unadjusted baseline data. 
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As shown in Table 3, no significant interaction was found for body mass, BMI, 
body fat %, fat mass and lean mass (p>0.05). Regarding dietary intake 
(expressed in Kcal), there were no significant differences at baseline and after 
the intervention program for either group (data not shown). 
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Table 3 – Adjusted anthropometric and biochemistry values and effects for the concurrent aerobic and resistance training 
intervention  
 Control Experimental Effect 
1
 Effect 
2
 Mean Difference 
 Baseline Final Baseline Final η
2
p η
2
p 95 % CI (LB to UB) 
Body Mass (kg) 65.8 (2.7) 65.6 (2.9) 67.9 (2.5) 68.5 (2.7) 0.017   
Body Mass Index (kg.m
-2
) 27.7 (0.9) 27.6 (1.0) 27.5 (0.9) 27.7 (0.9) 0.013   
Percentage of Body Fat (%) 38.7 (1.6) 38.7 (1.7) 38.3 (1.5) 37.4 (1.6) 0.033   
Fat Mass (kg) 25.1 (1.6) 25.2 (1.6) 25.6 (1.5) 24.9 (1.5) 0.016   
Lean Mass (kg) 37.4 (1.8) 37.5 (1.9) 39.0 (1.7) 39.7 (1.7) 0.031   
Leptin (ng.ml)
# 4.20 (0.5) 4.68 (0.5) 4.43 (0.4) 4.60 (0.5) 0.033       
Resistin (ng.ml)
# 2.40 (0.1) 2.46 (3.9) 2.60 (0.8) 2.55 (0.1) 0.011 
PAI-1 (ng.ml)
# 4.78 (0.4) 5.20 (0.3) 4.70 (0.3) 4.56 (0.3) 0.049 
Adiponectin (ug.ml)
# 3.45 (0.2) 3.62 (0.2) 3.33 (0.2) 3.22 (0.2) 0.102 
TNF-α (pg/mL) 6.20 (0.6) 3.40 (0.5) 4.13 (0.6) 3.98 (0.5) 0.193* 0.000 -0.007 (-1.442 to 1.427) 
Total Cholesterol (mg.dL)  197.3 (9.5) 205.3 (11.5) 215.1 (8.9) 211.6 (10.8) 0.063   
HDL Cholesterol (mg.dL) 51.2 (2.7) 48.5 (2.8) 55.9 (2.5) 48.2 (2.6) 0.181* 0.000 -0.328 (-8.645 to 7.989) 
LDL Cholesterol (mg.dL) 124.5 (8.3) 135.1 (10.0) 137.1 (7.8) 142.4 (9.4) 0.021 
Triglycerides (mg.dL) 108.1 (11.2) 107.7 (12.6) 110.3 (10.5) 104.9 (11.8) 0.005   
Glucose (mg.dL)
# 
9.53 (0.3) 9.65 (0.2) 9.70 (0.3) 9.40 (0.2) 0.098 
Total Physical Activity (Steps.day
-1
) 6983.1 (652.1) 7282.7 (748.5) 8061.2 (610.6) 9233.1 (700.9) 0.0002   
Notes: Data are expressed as mean (SE); * P<0.05 for group differences; ** P<0001 for group differences; Effect 
1
: Partial Eta Square (η2p) for group x time 
interactions; Effect 
2
: Partial Eta Square (η
2
p) for differences in the final evaluation; Mean Difference: differences between groups (Experimental – Control) at 
the final evaluations with values described as mean difference and respective 95% Confidence Interval (Lower Bound to Upper Bound). (#): Variables 
transformed for analysis (not normally distributed)
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3.1 Adipokines 
Exercise did not result in significant changes in adiponectin, leptin, 
resistin,TNF-α or PAI-1 concentrations (Table 3). 
 
3.2 Lipid profile and glucose  
 
There was a non-significant decrease in total cholesterol and triglyceride 
levels after training. HDL-cholesterol values significantly decreased post-
exercise in the EG [7.7±1.2 mg/dL; P < 0.001] with a significant main effect for 
group versus time interaction (P=0.014; η2p=0.181), but no differences in the 
final evaluation between groups (P > 0.05). LDL-cholesterol increased by 5.2 
± 4.2 mg/dL and 10.5 ± 4.5 mg/dL in the EG and CG, respectively. However, 
only in CG the difference was statistically significant in comparison with 
baseline (Table 3).  
 
4. Discussion  
 
The main finding of the present study is that 8 months of a moderate to high 
intensity, concurrent and supervised exercise intervention did not affect the 
levels of adipokines and glucose, or the lipid profile in older adults.  
We did not find a decrease in TNF-α levels, in agreement with previous 
studies with aerobic (Beavers and others 2013; O'Leary and others 2006) or 
resistance training (Bautmans and others 2005; Bruunsgaard and others 
2004; Prestes and others 2009; Reynolds and others 2004) in older adults. 
The effect of combined long-term training on TNF-α levels was evaluated in a 
randomized multicenter controlled trial with 424 elderly subjects; in this trial, 
there was no significant effect of training in TNF-α levels in a sequence of 
supervised-unsupervised training (Beavers and others 2010). Because TNF-α 
is produced within the adipose tissue (Coppack 2001), we hypothesize that 
the absence of decreased body fat (body composition) and BMI in our EG 
might have impacted our results. Also, studies that demonstrated significant 
decrease in TNF-α levels were conducted in patients with baseline elevated 
inflammatory TNF-α levels (e.g., in heart failure) (Larsen and others 2001; 
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LeMaitre and others 2004). Conversely, our population has a heterogeneous 
and less severe comorbidity profile with probable lower baseline levels of 
individual TNF-α concentrations. Also, it has already been demonstrated that 
exercise may elicit local anti-inflammatory effects that may not be evident in 
the systemic circulation, such as reduced TNF-α in local skeletal muscle in 
patients with heart failure after exercise training (Gielen and others 2003).  
Our results also suggest that 8 months of concurrent exercise do not improve 
leptin or adiponectin levels in older adults. Results from studies in overweight 
and obese individuals suggest that weight loss, rather than increased physical 
activity, is the lifestyle factor primarily responsible for improvement in these 
biomarkers (Beavers and others 2013; Rokling-Andersen and others 2007). 
Moreover, leptin declines after exercise training have been mainly confined to 
the untrained population (Noland and others 2001). However, our untrained 
older adults had no significant benefit of concurrent exercise in adiponectin or 
leptin levels. These results were also demonstrated in other studies in older 
adults (Beavers and others 2010; Jorge and others 2011; Ligibel and others 
2009; Markofski and others 2014). Thus, our results may be partly explained 
by the absence of a weight loss intervention protocol, some of which have 
been demonstrated to favorably impact adiponectin and leptin levels (Hulver 
and others 2002; Monzillo and others 2003; Rokling-Andersen and others 
2007). Also the observed absence of significant changes in dietary intake 
during the training period in our study may corroborate these results (data not 
shown). Nonetheless, some previous studies have shown that combined 
aerobic and resistance (Gondim and others 2015) or only resistance 
(Fatouros and others 2005) training in older adults has a positive impact on 
adiponectin and leptin levels. The conflicting results among the previously 
mentioned studies on the relationship of leptin and adiponectin levels and 
exercise might also be attributed to the heterogeneity in intensity and duration 
of training protocols. It might be that the 30 minutes of aerobic training in our 
study were not long enough to produce a favorable effect in combination with 
the resistance activity. 
To our knowledge, this is the first study that examined the effects of long-term 
concurrent exercise on resistin levels in an older population and reported a 
non-significant reduction of this hormone after combined exercise. Resistin is 
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an adipocyte-released hormone with a physiological association with obesity 
and insulin resistance. Gondim et al demonstrated that resistin levels 
decrease with 12 months of regular combined training in 143 overweight and 
obese subjects with a median age of 56 years, independently of weight loss 
(Gondim and others 2015). Our study results are in accordance with a study 
in younger diabetic patients (median age of 48), in whom combined training 
did not change resistin levels (Jorge and others 2011).  This effect was also 
previously demonstrated in other studies with resistance training alone (Jones 
and others 2009; Kanaley and others 2001). Resistance training studies in 
diabetic patients that combined dietary intervention also did not have an 
impact on resistin levels (Giannopoulou and others 2005; Monzillo and others 
2003). Thus it is possible that the changes in resistin levels did not achieve 
significant results because the present study did not included only overweight, 
obese or diabetic older subjects. 
 
Circulating PAI-1 levels increase with age and are predictive of the incidence 
of acute cardiovascular events in the general population (Cesari and others 
2010; Thogersen and others 1998). In accordance with one previous study in 
post-menopausal women with 6-month concurrent resistance and aerobic 
training (Rossi and others 2017), our study did not show significant 
differences in PAI-1 levels after training. Epidemiological cross-sectional 
studies have shown that active middle-aged people have lower fibrinogen and 
PAI-1 levels as compared with non-active persons (Lakka and Salonen 1993; 
Szymanski and Pate 1994). Previous studies suggest beneficial effects of 
isolated aerobic or resistance physical training on fibrinolysis. A 6-month 
intervention randomized study with regular aerobic exercise in 182 sedentary 
and non-sedentary elderly healthy subjects demonstrated a significant 
reduction in PAI-1 antigen concentrations (Schuit and others 1997).  Chandler 
et al observed a reduction in PAI-1 levels in 25 older healthy subjects 
following a 6-month endurance training program (Chandler and others 1996). 
Our study results might be in part justified by the absence of weight loss 
intervention, as PAI-1 is also secreted by adipose tissue, and previous studies 
put in evidence that a weight loss intervention lifestyle program (Belalcazar 
and others 2011), also when combined with aerobic training (Duggan and 
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others 2016), provided significant reductions in PAI-1 levels in older 
subjects. It is interesting to note that an association has been found between 
the acute phase proteins and triglycerides and HDL-cholesterol in an elderly 
population (Schuit and others 1997). In our study, the lipid profile levels did 
not improved, and this might be associated with the absence of decreased 
PAI-1 levels. Indeed, our study did not control for variables such as smoking 
or alcohol consumption before serum measures of PAI-1, and this may have 
interfered in the observed results. 
 
The observed impact of concurrent training in the lipid profile was unexpected. 
In fact, several studies have reported significant positive effects of chronic 
exercise on lipoproteins (Durstine and others 2002; Pedersen and Saltin 
2006). Nevertheless, data from other comprehensive reviews (Durstine and 
others 2001; Leon and Sanchez 2001) suggest that exercise has little effect 
on LDL-C concentrations, and the most consistent effect of physical training 
on plasma lipids is the change in plasma concentrations of HDL-cholesterol. 
Studies demonstrated that the effect of exercise (mostly aerobic exercise) on 
lipid profile is frequently combined to and generally attributed to weight loss 
(Poirier and others 1996). Indeed, in our study no significant changes 
occurred in body fat mass and BMI. 
 
The strengths of this study are the presence of a control group, dietary 
recording, daily physical activity, duplicated biochemical analysis, and an 
accurate body composition evaluation by DEXA scans. However, some 
limitations must be acknowledged. The small sample size and absence of 
randomization limited the power of our analysis and the interpretation of the 
results.  
 
Although our study results provide some insights concerning the effect of an 
8-month program of concurrent aerobic and resistance exercise on 
inflammatory biomarkers, additional studies are needed in older subjects, also 
including inflammatory immune-cell chemokines in addition to adipokines 
(Gleeson and others 2011). Endurance and resistance trainings are two 
common modalities of physical training. The results show that concurrent 
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training, which is a combination of endurance and resistance training, do not 
significantly impact lipid and adipokines levels. It seems that the adipokine 
concentrations could be affected by morphological alterations, given its 
potential connections with body composition, namely fat mass. Future 
multidisciplinary investigations in older adults should be encouraged in order 
to provide better understanding about the biological and physiological 
grounding of the different exercise regiments during aging.  
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Published studies evaluating adiponectin and leptin levels in parallel to lipid 
profile and body composition (Cnop et al., 2003; Im et al., 2006; Mazzali et al., 
2006; Park et al., 2004; Rolland et al., 2006; Staiger et al., 2003; Zoccali et 
al., 2002) did not focus exclusively in older adults. It has been demonstrated 
that the plasma levels of these adipokines to be correlated with an 
atherogenic lipoprotein profile and body fat distribution (Cnop et al., 2003; Im 
et al., 2006; Mazzali et al., 2006). The first cross-sectional study of this thesis 
(Study I), included 34 untrained older subjects, and the results suggested that 
leptin levels are positively influenced by body mass and negatively correlated 
with lean mass, corroborating with data describing that leptin secretion is 
higher in obese subjects (Proenca et al., 2014). As demonstrated in previous 
studies (Ouchi et al., 2003; Rolland et al., 2006; Ryo et al., 2004), our results 
showed that adiponectin plasma levels are negatively correlated with 
abdominal fat mass. These results confirmed the ones described in the 
literature for obese and non-obese adults (Brennan et al., 2007; Welsh et al., 
2009). However, we did not expect to demonstrate a positive association 
between adiponectin and BMI levels, that might be explained by the finding of 
an increased lean mass in detriment of fat mass in these older subjects. Our 
methodology had the advantage to include precisely performed DXA 
evaluation in addition to standard anthropometric measurements. 
The next step of this work was to evaluate the impact of combined training in 
physical fitness of these older adults. The International physical activity 
guidelines include both endurance and resistance training for older adults, 
also as means to reduce frailty and increase physical function (American 
College of Sports et al., 2009). As stated before, endurance training mainly 
improves aerobic capacity and reduces body fat, while resistance training 
primarily results in increases in muscle strength and mass (American College 
of Sports et al., 2009). The objective of the study II was to underline the 
importance of concurrent endurance and resistance training to improve 
physical fitness in sedentary older adults. This study demonstrated that eight-
month concurrent endurance and resistant training increased lower-limb 
isokinetic strength for knee flexors, muscular endurance and flexibility in 
community-dwelling older adults. These results are interesting as, so far, few 
studies have included exclusively older subjects to address the flexibility and 
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muscular endurance with concurrent longer term training approach (Carvalho 
et al., 2009; Cress et al., 1999; Ferrari et al., 2013; Gudlaugsson et al., 2012). 
Our results with long-term concurrent training demonstrated a significant 
increase in lower-limb strength, especially for peak torque of knee flexors. Lee 
et al (Lee et al., 2015) also demonstrated that the absolute peak torque in 
concurrent training increased significantly more than it did in the aerobic 
isolated training group. These authors found a significant increase in the 
flexion and extension after 8 weeks of training but 5 times per week. Two 
studies with shorter period of combined training demonstrated a significant 
improvement of knee extension (Ferrari et al., 2016; Gudlaugsson et al., 
2012). However, in accordance with our results, no significant improvement in 
isokinetic knee extension was noted in the study of Ferrari et al (2013) (Ferrari 
et al., 2013) that used longer (20 week) concurrent training with less frequent 
sessions. Probably for this type of contraction in these muscle groups a higher 
frequent training sessions is required (Lee et al., 2015).  
Two functional ability tests (arm curl and chair stand) that have been validated 
as measures of muscle strength (Rikli, 1999) were conducted in the present 
study to establish the effects of combined training. In accordance to previous 
studies we demonstrated improved chair stand performance (Carvalho et al., 
2009; Cress et al., 1999; King et al., 2000; Toraman et al., 2004; Wilhelm et 
al., 2014) with concurrent training in older adults. Despite no significant 
changes were observed in isokinetic knee extension muscle strength, 
functional improvements were observed after the concurrent training. In fact 
rising from a chair, that involves transferring the body's center of mass from a 
low position to a high position, is considered one of the mechanically 
demanding activities executed in everyday life, since it requires not only 
muscle strength but also dynamic balance (Riley et al., 1991).  
The flexibility loss with aging is associated with muscle disuse and soft tissue 
restraints, with a consequent deterioration of functional abilities in this 
population (American College of Sports et al., 2009). Our study demonstrated 
a significant improvement in lower flexibility measured by sit and reach test, in 
accordance with another similarly designed study in older adults (Carvalho et 
al., 2009). However, contrary to Carvalho et al (2009), there was no significant 
improvement in the upper flexibility (Carvalho et al., 2009). It is interesting to 
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note that in our study there was no specific training for the improvement of 
flexibility. 
Most studies demonstrated that concurrent resistance and aerobic training 
improve cardiorespiratory fitness measured by 6-min walk test (Gudlaugsson 
et al., 2012; Toraman et al., 2004) or VO2 max (Cadore et al., 2012; Cadore et 
al., 2011; Cress et al., 1999; Ferrari et al., 2016; Takeshima et al., 2004; 
Wilhelm et al., 2014) in older adults. Although there was a 31-meter increase 
in the distance walked in the EG of the current study, this difference was not 
statistically significant in comparison with baseline. Carvalho et al (Carvalho et 
al., 2009) published similar results in elderly women, with twice a week and 60 
min session combined training. This lack of improvement in both studies might 
be explained by the lower frequency and duration of aerobic exercise 
sessions. According to Gudlaugsson et al (Gudlaugsson et al., 2012), 30 min 
of ET daily with twice-weekly RT seems to be necessary to improve 6MWT 
performance.  
Since regular exercise can promote cardiovascular health through 
improvement in the blood lipid profile, by decreasing the concentration of LDL 
particles and increasing the concentration of protective HDL cholesterol, 
limiting atherosclerosis (Gleeson et al., 2011), and also, be recognized as an 
important anti-inflammatory effect (Kasapis & Thompson, 2005; Pedersen & 
Saltin, 2006) we finally evaluated the impact this exercise intervention in lipid 
profile and adipokine levels of older adults.  
Previous studies with aerobic (Beavers, Ambrosius, et al., 2013; O'Leary et 
al., 2006) or resistance training (Bautmans et al., 2005; Bruunsgaard et al., 
2004; Prestes et al., 2009; Reynolds et al., 2004) in older demonstrated 
improvement in adipokine profile. However, few studies with concurrent 
combined training were published so far, with no significant improvements 
demonstrated (Beavers, Hsu, et al., 2010; Brooks et al., 2007; Gondim et al., 
2015; Jorge et al., 2011; Ligibel et al., 2009; Markofski et al., 2014). 
Therefore, in study III we intended to evaluate if concurrent combined aerobic 
and resistance training was effective to improve lipid profile and adipokines in 
community older adults. In opposition to our initial hypothesis, with the 
recognized limitation of the sample size (n=18), our study with long-duration 
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(8-months), high intensity and combined supervised training did not 
demonstrate a significant decrease in TNFα, leptin, resistin and PAI-1 levels 
or a significant increase in adiponectin levels in older adults.  
In accordance to previous studies with aerobic (Beavers, Ambrosius, et al., 
2013; O'Leary et al., 2006) or resistance training (Bautmans et al., 2005; 
Bruunsgaard et al., 2004; Prestes et al., 2009; Reynolds et al., 2004) in older 
adults, combined exercise did not decrease TNF-alfa levels. The effect of 
combined long-term (12 months) training in TNF-alfa levels was evaluated in 
a randomized multicenter controlled trial with 424 elderly subjects. In this trial, 
there was no significant effect of combined training on TNF-alfa levels 
(Beavers, Hsu, et al., 2010).  As in our study, a concurrent approach was also 
performed, but with a different training protocol with supervised-unsupervised 
training. Because TNF-alfa is produced within the adipose tissue (Coppack, 
2001), we  hypothesized that the absence of decreased body fatness (body 
composition) and BMI in the exercise group might have impacted our results. 
Moreover, the small sample size and absence of randomization that limited 
the power of our analysis should be taking into account for the interpretation 
of our data. Also, previous studies that demonstrated significant decrease in 
TNF-alfa levels were conducted in patients with baseline elevated 
inflammatory TNF-alfa levels (e.g., heart failure) (Larsen et al., 2001; LeMaitre 
et al., 2004). Conversely, our population has a heterogeneous and less 
severe comorbidity profile, where relatively baseline lower levels of individual 
TNF-alfa concentrations might not be excluded. It has also been 
demonstrated that exercise may elicit local anti-inflammatory effects that may 
not be evident in the systemic circulation, such as reduction TNF-alfa in local 
skeletal muscle in patients with heart failure after exercise training (Gielen et 
al., 2003).  
Moreover, our results showed that 8 months of combined exercise did not 
improve leptin and adipokine levels in older adults. Results from studies in 
overweight and obese individuals suggest that weight loss, rather than 
increased physical activity, is the lifestyle factor primarily responsible for 
improvement in these biomarkers (Beavers, Ambrosius, et al., 2013; Rokling-
Andersen et al., 2007). According to previous studies, leptin decline after 
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exercise training was mainly confined to an untrained population (Noland et 
al., 2001). However, our untrained older adults had no significant benefit of 
combined exercise in adiponectin and leptin levels. These results were also 
demonstrated in other studies in older adults (Beavers, Hsu, et al., 2010; 
Jorge et al., 2011; Ligibel et al., 2009; Markofski et al., 2014). Our results 
might be partly explained by the absence of a weight loss intervention 
protocol, which has been demonstrated to favorably impact on adiponectin 
and leptin levels (Hulver et al., 2002; Monzillo et al., 2003; Rokling-Andersen 
et al., 2007). Also, the observed absence of significant change in dietary 
intake during the training period in our study might corroborate these results. 
Nonetheless, some previous studies have shown that combined aerobic and 
resistance (Gondim et al., 2015) or specific resistance (Fatouros et al., 
2005)(Fatouros et al., 2005)(Fatouros et al., 2005)(Fatouros et al., 
2005)(Fatouros et al., 2005)(Fatouros et al., 2005) training (Fatouros et al., 
2005) in older adults had a positive impact in adiponectin and leptin levels. 
The conflicting results among all previous mentioned studies on the 
relationship of leptin and adiponectin levels and exercise might also be 
attributed to the heterogeneity in intensity and duration of training protocols. It 
might be that the 30 minutes of aerobic training in our study were not long 
enough to produce a favorable effect in combination with the resistance 
activity. 
To our knowledge, this is the first study that examined the effects of long-term 
combined exercise on resistin levels in an older population and reported a 
non-significant reduction of this hormone after 8 months of combined 
exercise. Gondim et al demonstrated that resistin levels decrease with 12-
month regular combined training in 143 overweight and obese subjects with a 
median age of 56, independently of the weight loss (Gondim et al., 2015). Our 
study results are in accordance with a study in younger diabetic patients 
(median age of 48) where combined training did not change resistin levels 
(Jorge et al., 2011).  This effect was also previously demonstrated in other 
studies performed with exclusive resistance training (Jones et al., 2009; 
Kanaley et al., 2001). Resistance training studies in diabetic patients that 
combined dietary intervention also did not have impact on resistin levels 
(Giannopoulou et al., 2005; Monzillo et al., 2003). It could be that, as this 
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study did not included only overweight, obese or diabetic older subjects, the 
changes in resistin levels did not attain a significant level. 
In accordance to one previous study in post-menopausal women with 6-month 
concurrent resistance and aerobic training (Rossi et al., 2017), our study did 
not show significant differences in PAI-1 levels after training. Epidemiological 
cross-sectional studies have shown that active middle-aged people have 
lower fibrinogen and PAI-1 levels as compared with non-active persons 
(Lakka & Salonen, 1993; Szymanski & Pate, 1994). Previous studies suggest 
beneficial effects of isolated aerobic or resistance physical training on 
fibrinolysis. A 6-month intervention randomized study with regular aerobic 
exercise in 182 sedentary and non-sedentary elderly healthy subjects 
demonstrated a significant reduction in PAI-1 antigen concentrations (Schuit 
et al., 1997).  Chandler et al, observed a reduction in PAI-1 levels in 25 older 
healthy subjects following a 6-month endurance training program (Chandler et 
al., 1996). Our results might be in part justified by the absence of weight loss 
intervention, as PAI-1 is also secreted by adipose tissue and previous studies 
put in evidence that a weight loss intervention lifestyle program (Belalcazar et 
al., 2011), provided significant reductions in PAI-1 levels in older subjects. It is 
interesting to note that an association has been demonstrated between the 
acute phase proteins and triglycerides and HDL-cholesterol in an elderly 
population (Schuit et al., 1997). In our study, lipid profile levels did not 
improved and this might be associated with the absence of decreased PAI-1 
levels. Indeed, our study did not control for variables such as smoking or 
alcohol consumption before serum measures of PAI-1 and this could interfere 
in observed results. 
The impact of concurrent training in lipid profile parameters observed in our 
study was unexpected. In fact, several studies have reported significant 
positive effects of chronic exercise on lipoproteins (Durstine et al., 2002; 
Pedersen & Saltin, 2006). Nevertheless, data from other comprehensive 
reviews (Durstine et al., 2001; Leon & Sanchez, 2001) suggest that exercise 
has little effect on LDL-cholesterol concentrations, and the most consistent 
effect of physical training on plasma lipids is the change in plasma 
concentrations of HDL-cholesterol. Studies demonstrated that the effect of 
exercise (mostly aerobic exercise) on lipid profile is frequently combined to 
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and generally attributed to weight loss (Poirier et al., 1996). Indeed, in our 
study no significant changes occurred in body fat mass or BMI. 
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Chapter 6 – Conclusions 
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Based on the analysis of the results drawn from different studies presented in 
this thesis, it is possible to conclude that, in community older adults: 
• Leptin is a dependent variable of body mass and lean mass, and 
adiponectin is a dependent variable of abdominal fat mass and HDL 
cholesterol. 
 
• Eight-month concurrent ET and RT increased lower-limb isokinetic strength 
for knee flexors, muscular endurance and lower-limb flexibility in older 
adults.  
 
• Eight-month concurrent ET and RT was not effective to improve isokinetic 
peak torque of knee extension and cardiorespiratory fitness. 
 
• Eighth-month combined aerobic and resistance exercise intervention did 
not affect the levels of adipokines (named as TNF-α, leptin, resistin, PAI-1, 
adiponectin), glucose, and lipid profile in older adults.  
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Attachments –  
 
Appendix I – Written informed consent 
 
 
 
 
Carta de Consentimento/ Termo de Responsabilidade 
 
Para a presente investigação, os participantes serão submetidos a uma série de procedimentos de 
avaliação de parâmetros relacionados com a aptidão física e a saúde, nomeadamente: 
• Avaliação da composição corporal;  
• Análises de amostra sanguínea;  
• Medidas de Pressão Arterial e Frequência Cardíaca em repouso e em exercício;  
• Inquérito sobre estado de saúde percebido;  
• Inquérito sobre hábitos nutricionais; Avaliação do nível de actividade física habitual;  
• Testes de Aptidão física (equilíbrio, força muscular e aptidão cardiorespiratória). 
Os dados recolhidos na pesquisa terão fins exclusivamente científicos, a identidade de cada 
participante será preservada. Espera-se, que os resultados deste estudo forneçam subsídios para o 
melhor entendimento do papel do exercício em algumas variáveis da aptidão física e saúde. Os 
resultados deste estudo estarão à disposição dos participantes mediante a solicitação dos mesmos, ao 
professor responsável. Nos casos onde forem detectadas restrições à prática de exercícios de 
intensidade moderada a vigorosa, serão sugeridos: 1) o afastamento provisório do programa de 
exercício e 2) a procura a um fisioterapeuta para tratamento adequado. Os voluntários têm ainda, o 
direito de abandonar a pesquisa, a qualquer momento, caso não se sintam satisfeitos. 
Estando informado das intenções e dos propósitos desta pesquisa, 
eu,_________________________________________________________declaro que participo 
voluntariamente nos projectos de doutoramento do Sr. Eduardo Arend, do Programa de Doutoramento 
em Actividade Física e Saúde da Faculdade de Desporto da Universidade do Porto, com orientação 
pela Profa. Dra. Joana Carvalho. Ainda, ciente de que a realização de actividade física pode acarretar 
algum risco clínico, declaro que me assegurei, previamente, de que não tenho quaisquer contra-
indicações para a prática da actividade física e aceito todas as responsabilidades inerentes à 
participação no Programa de Actividade Física Sénior. 
Pela presente declaração, isento de qualquer responsabilidade a Faculdade de Desporto por alguma 
alteração do meu estado de saúde, decorrente directa ou indirectamente do programa de exercícios. 
Faculdade de Desporto da Universidade do Porto, Porto ____ de ____________________ de 2010.  
__________________________                                        ____________________________ 
Nome do participante                                                                         Assinatura do participante 
 
Faculdade de Desporto da Universidade do Porto, Porto____ de ____________________ de 2010. 
__________________________                                                     _____________________________ 
Nome do investigador                                                                            Assinatura do investigador 
Centro de Investigação em Actividade Física, 
Saúde e Lazer 
